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11. Introduction
1. Introduction
1.1. Toxicity in the lungs
The degree to which a substance is able to damage an exposed organism is defined by 
the term toxicity. This toxicity can further be specified by the way the organism is affected 
by the toxicant. It can either affect the whole organism, as well as substructures like 
cells (cytotoxicity) or specific organs. Referring to the lungs toxicity towards the organ 
can be classified in two ways: the route of exposure and the source of the toxicant. As 
the lungs constitute the blood/air interface, the possible routes of exposure are via the 
cardiovascular system and by inhalation. Among the possible sources, the two most 
important groups are chemical substances and physical stimuli.
1.1.1. Chemical substances
1.1.1.1. Xenobiotics
Xenobiotics are chemicals found in organisms, which are normally not present or 
endogeneously produced. The body removes xenobiotics by xenobiotic metabolism 
consisting of chemical modification and secretion (Fig. 1.1). Although the liver is 
considered to be the most important organ in drug metabolism, other organs like 
the lungs can contribute significantly to the biotransformation of a compound in the 
body. Biotransformation is the process by which cells modify xenobiotics to facilitate 
the elimination of lipophilic substances to avoid accumulation in cell lipids. This 
biotransformation is maintained by mostly unspecific enzymes which can be found in 
the membranes of the endoplasmatic reticulum and mitochondria or unaffiliated in the 
cytoplasm. In a first step the xenobiotic is oxygenised, reduced or hydrolysed by phase I 
enzymes resulting in the appearance of more polar and reactive functional groups 
in the molecule (179). The hemoproteins encoded by the CYP genes (cytochrome 
P450-depending monooxygenases) are considered to be the most actively involved 
phase I enzymes and their expression pattern in the lung is well characterised (35). 
In general, biotransformation reactions are beneficial, although sometimes these 
enzymes transform otherwise harmless substances into more reactive intermediates, 
a process known as bioactivation. A classic example is the bioactivation of benzo(a)
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pyrene into reactive forms capable of generating DNA adducts eventually leading to 
cancer formation in the lung (35). 
The process is followed by a conjugation with endogenous molecules such as 
glucuronic acid, glutathione, sulphate and amino acids (Phase II reactions). Linking the 
xenobiotic to compounds produced by the organism allows renal or biliary secretion 
(179).
Situated at the air/blood interface the lung is a prominent target organ for 
chemically induced damage resulting from exposure to xenobiotics after inhalation 
or accumulation in the lung following systemic administration. Biotransformation 
depends on the amount and activity of transporting and metabolising enzymes 
present. Bronchial epithelial cells, alveolar epithelial cells, alveolar macrophages and 
Clara cells seem to be the most important cells for xenobiotic metabolism and toxicity. 
They possess a variety of metabolising enzymes and especially Clara cells show a high 
amount of cytochrome P450 mediated metabolism (35; 115). 
Some examples of harmful chemicals to which the lung is accidentally or occupationally 
exposed by inhalation are polycyclic aromatic hydrocarbons, aromatic amines, 
halogenated compounds, aliphatic compounds, aldehydes and ketones (35). 
Lung toxicity was mainly studied in relation to mutagenic and carcinogenic compounds 
from tobacco smoke (89). In addition, a specific lung toxicant due to particular 
accumulation is the widely used herbicide paraquat. Other specific lung toxicants that 
have been studied are 4-ipomeanol, bleomycin, naphthalene and dichloroethylene 
(89).
Figure 1.1:   Simplified scheme of metabolism and bioactivation of xenobiotics. From 
reference (35). GST = glutathion S-transferase, UGT = UDP-glucuronyltransferase, EH 
= epoxide hydrolase, ST = sulphotransferase, NAT = N-acetyltransferase.
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1.1.1.2. Allergens and mediators
Atopic individuals respond to common, environmental antigens with an inappropriate 
IgE-production leading to hypersensitivity. IgE binds to the high affinity Fcε-receptor 
on mast cells (which can be found in the tissue at entry sites), circulating basophils and 
activated eosinophils (177). 
Cross-linking of the bound IgE activates mast cells characterised by a degranulation 
which occurs within seconds (22). Histamine as one of the preformed mediators 
enhances vascular permeability and contracts smooth muscles (104). Mast cell 
derived enzymes like chymase, tryptase and serine esterases activate matrix-
metalloproteases which alter matrix proteins and TNFα activates endothelial cells. 
Besides preformed mediators mast cells newly synthesise and secrete a variety of 
mediators (177): Chemokines (MIP-1a), PAF and cytokines (IL-4, IL-13, IL-3, IL-5, GM-
CSF and TNFα) maintain the acute and chronic inflammatory response by attraction 
of other inflammatory cells like T-lymphocytes, basophils and eosinophils (177). 
Arachidonic acid is produced from membrane phospholipids and metabolised to 
prostaglandins, thromboxanes and leukotrienes (176). These lipid mediators cause 
bronchoconstriction, vasoconstriction, enhanced vascular permeability and stimulate 
mucus secretion intensifying the inflammatory response.
Mast cell mediators and Th2-cytokines, namely IL-5, Eotaxin-1 and -2, accumulate and 
activate eosinophils and basophils which secrete a wide range of toxic proteins and 
enzymes in addition to cytokines, chemokines and lipid mediators (177). 
The inflammatory response to an allergen occurs in two phases: the early allergic 
response and the late phase response. The early allergic response develops as a 
consequence of released and synthesised toxic mediators from mast cells resulting in 
enhanced vascular permeability and bronchoconstriction (177). 
Induced synthesis of leukotrienes, chemokines and cytokines in activated mast cells 
trigger the late phase response by mobilising leukocytes like eosinophils and Th2-
lymphocytes to the focus of inflammation. The late phase response is characterised 
by a second contraction of the smooth muscle, ongoing edema and promotes the 
formation of airway hyperresponsiveness. The hyperresponsiveness to unspecific 
stimuli is often due to chronic inflammation of the airways even in the absence of the 
allergen (177). 
The most severe symptom of allergic asthma, which can become life-threatening, 
is constriction of the airways with airflow limitations. Reversibility of these airway 
obstructions is often only possible by treatment with ß-agonists or steroids as long 
term medication.
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1.1.1.3. Clinical relevance: Asthma bronchiale
Asthma bronchiale is one of the most common types of occupational lung diseases in 
developed countries. In Germany 10 % of the children and 5 % of the adult population 
develop asthma bronchiale (218). A wide range of industrial chemicals can induce 
such respiratory allergic reactions and lead to the manifestation of occupational 
asthma. Industrial organic chemicals like toluene isocyanate, reactive dyes and acid 
anhydrides, such as trimellitic anhydride (TMA) are already known or are suspected 
to cause respiratory allergy and occupational asthma (17; 257; 313). Whereas the 
specific mechanisms of the respiratory sensitisation by such chemicals are still not 
fully elucidated hypersensitivity seems to be associated with the development of a 
Th2-profile (11; 61; 62). Skin sensitisers, such as 2, 4-dinitrochlorobenzene, normally 
Figure 1.2:  Simplified scheme of allergen exposure and airway inflammation. Degranulating 
mast cells and activated Th2-cells recruit leukocytes from the blood via transmigration. Released 
histamine and leukotriene leads to bronchoconstriction, mucus secretion and hyperreactivity of the 
airway. Activated B cells produce and release IgE. Secreted granule proteins of eosinophils injure 
the airway.
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induce a Th1 cytokine phenotype (59; 105; 277). Nevertheless some skin sensitisers, 
e.g. dinitrofluorobenzene and trinitrochlorobenzene, are able to induce an IgE-
independent hyperreactivity (32; 82-84).
1.1.2. Physical toxic stimuli
1.1.2.1. Mechanical forces in the lung
The lung is subjected to varying mechanical forces throughout development and 
life. Lung cells in their complex three-dimensional structure are exposed to different 
physical forces. Strain (change in length in relation to the initial length), stress (force 
per unit area), hydrostatic pressure and shear stress (force per unit surface area in the 
direction of flow exerted at the fluid/surface interface) are of capital importance in the 
lung. While cells of the alveolar walls and the epithelium are primarily subjected to 
stress and strain, shear forces appear mostly in the vascular endothelium (301). 
Sensing physical stimuli is therefore a crucial mechanism to assure adequate lung 
functions. Airway sensors constantly transmit mechanical changes through vagal 
and other afferent pathways to the central nervous system to evoke reflex responses. 
Such specialised mechanoreceptors called rapidly adapting receptors (RARs) occur 
throughout the respiratory tract from the nose to the bronchi (99; 308). Besides 
these specialised structures there are mechanosensors localised on the cytoplasmic 
membrane that are able to respond to mechanical forces applied to cells or generated 
internally. Mechanosensors comprise stretch-activated ion channels, the extracellular 
matrix-integrin-cytoskeleton network, growth factor receptors and cell-cell adhesion 
molecules (99).
However, quantification of the extent to which different cell types undergo mechanical 
deformation is complicated. The kind of forces which are relevant in alveolar regions 
during breathing is still under discussion. Besides the notion that alveoli may extend 
during breathing, it has also been suggested that the inspired air flows in newly 
recruited airways, into ducti alveolares (34) or into recruited alveoli (73; 112; 254).
Physical forces during mechanical ventilation gain importance in association with 
pathophysiologic processes in injured lungs. Components that are associated 
with the so called ventilation-induced lung injury (VILI) are high tidal volumes and 
pressures (volutrauma, barotrauma), release of mediators leading to activation of 
inflammatory pathways (biotrauma) and repeated opening and closure of alveolar 
units (atelectotrauma) (201; 270). 
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Heterogeneity of the injured lung reduces the lung volume and predisposes the lung 
to mechanical forces which are physiologically abnormal. This is especially important 
when local distending forces differ to oppose heterogeneity and to restore lung 
expansion.
In general, the mechanical forces applied during ventilation can injure the lung in two 
ways: by physical disruption or activation of cytotoxic or proinflammatory responses. 
1.1.2.2. Barrier disruption
The alveolar-capillary barrier is formed by the microvascular endothelium and the 
alveolar epithelium. To allow adequate gas exchange the alveolar-capillary membrane 
has to be extremely thin, resulting in an alveolar septum of 5 to 8 µm. Two different 
cell types form the alveolar epithelium: Flat alveolar type I cells which line 90% of the 
alveolus area and cuboidal type II cells functioning mainly as surfactant producing and 
secreting cells besides their function in ion transport. Alveolar type I cells may undergo 
extensive necrosis during lung injury. To a certain extend alveolar type II cells are 
capable of differentiation into type I cells to regenerate the epithelium. Consequences 
arising out of the loss of epithelial integrity are numerous. Normally the epithelial 
barrier is much less permeable than the endothelium which prevents leakage of fluid 
into the alveolus (295). Epithelial injury can therefore contribute to alveolar flooding 
(287). Injury to alveolar type II cells impairs the normal function to remove the fluid 
and furthermore reduces surfanctant production (91; 143). 
The phenotype of alveolar type I cells being fragile in response to stretch in 
combination with the recruitment of inflammatory and reparative cells can lead to 
insufficent epithelial repair. The formation of hyaline membranes in alveolar walls and 
healing under profibrotic conditions can be the consequence (201; 287). Mechanical 
ventilation exposes the endothelium and the alveolar epithelial cells to relatively high 
wall stress. This induces also tensile strain and shear forces in the lung. Stress failure 
of capillaries occurs at high transmural pressures and high lung volumes probably 
due to increased longitudinal forces (79). Mechanical strain reduces the active sodium 
transport-dependent clearance of edema fluid from the airspaces. By filling alveoli 
and airways and additional inactivating surfactant the lung volume is reduced. Hence 
heterogeneity of the lung is promoted and results in greater overdistension of the 
remaining lung units accompanied with greater shear stress (79). Disruption of the 
alveolar-capillary barrier and increased permeability is an important mechanism 
responsible for the formation of alveolar edema. Release of inflammatory mediators 
into the circulation as a result of the loss of compartmentalisation is suspected to play 
a role in multisystem organ failure (79; 201). 
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1.1.2.3. Inflammation
A potential mechanism of ventilator-induced lung injury is the increased inflammation 
in response to mechanical stimuli. Overventilation activates canonical inflammation 
pathways in alveolar epithelial and endothelial cells by activation of transcription 
factors, such as NFκB. Cytokines (e.g. IL-1ß, TNFa, IL-6), chemokines (e.g. IL-8) and 
adhesion molecules are produced to recruit inflammatory cells into the airspace and 
bloodstream. Besides macrophages especially neutrophils seem to play an important 
role in the pathogenesis of acute lung injury (79; 201; 270). 
1.1.2.4. Clinical relevance: ALI and ARDS
Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS) are life-
threatening disorders accompanied with a high mortality (2). They are characterised 
by a diffuse inflammation of the lung parenchyma triggered by an initial release of 
inflammatory mediators from endothelial and epithelial cells. Undefined alveolar 
damage leads to hypoxia and frequently to multiple organ failure.
In 1994 a new definition was recommended by the American-European Consensus 
Conference Committee. Since then ARDS is characterised by an acute onset, bilateral 
infiltrates on chest radiography and a pulmonary-artery wedge pressure of ≤ 18 mmHg 
or the absence of clinical evidence of left atrial hypertension. ARDS is considered to be 
present if PaO2:FiO2 ≤ 200 mmHg, if the PaO2:FiO2 is ≤ 300 mmHg ALI is indicated, a 
milder form of ARDS considered as a precursor (287). 
ARDS is a severe lung disease caused by a variety of clinical disorders that cause 
direct or indirect lung injury. Direct lung injury may be caused by pneumonia or the 
aspiration of the gastric contents, while indirect lung injury is caused in the setting of 
a systemic process such as sepsis or severe trauma. 
In spite of the advances in supportive care and research a high morbidity accompanied 
by a high mortality remains. Only one phase III trial study publicated in 2000 by the 
ARDSnet ever showed a significant reduction of mortality, i. e. from 39.8 % to 31 % by 
reducing the tidal volume from the conventional 12 ml/kg to 6 ml/kg (2). 
Although indispensable, mechanical ventilation of patients with respiratory 
failure has still adverse effects (79; 201). Lungs of ARDS patients are typically 
injured inhomogeneously which leads to overexpansion of intact lung areas. This 
overexpansion is assumed to cause ventilator-induced lung injury – both mechanically 
and by activation of the innate immune system (Biotrauma hypothesis) (68; 95).
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1.1.2.5. Biotrauma hypothesis
The leading cause of death in patients with ARDS is the sepsis syndrome and multiple 
organ dysfunction syndrome rather than respiratory failure (170). Mechanical 
ventilation seems to be one factor responsible for this negative association (239). A 
number of animal and clinical studies have shown that mechanical ventilation per 
se can worsen pre-existing lung injury and produce VILI (69; 156; 201; 203; 263). The 
mechanism how mechanical ventilation exerts its detrimental effect is still unclear. 
Overdistension of the lung and shear forces generated during repetetive opening and 
collapse of atelectic regions exacerbate, or even initiates, lung injury and inflammation 
(67). Usually stretch is not pathologic for the lung and actually an important factor for 
lung growth and development, and for surfactant production (301). The altered pattern 
or magnitude of the lung stretch during mechanical ventilation could lead to alterations 
in gene expression and cell metabolism and to an upregulation of an inflammatory 
response (67; 263). Clinical studies and animal experiments support the hypothesis 
evidencing the release of proinflammatory mediators by hyperventilation correlating 
with multiple organ failure (116; 215; 252; 270; 283). Loss of compartmentalisation of 
the pulmonary response could trigger the release of inflammatory mediators in the 
systemic circulation followed by a compensatory anti-inflammatory response. The 
incapability of the organism for immune modulation or the persisting pulmonary 
injury may eventually lead to death (67). 
Until today the mechanosensor in stretched lung tissue has not been conclusively 
identified. However, the transient receptor potential vanilloid-4 (TRPV4) channel 
may act as mechanosensitive cation channel (96). Dos Santos et al. suggested some 
mechanisms of mechanotransduction involving ion-channels, plasma membrane 
integrity and direct conformational changes in membrane associated molecules (Fig. 
1.3). 
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Crucial signal transduction pathways that have been identified include the activation 
of NFkB, mitogen-activated protein kinases, Elk-1, ATF2, AP-1 and phosphoinositide-3- 
kinase (107; 132; 144; 146; 271; 272). This indicates that mechanical ventilation activates 
largely the same inflammatory mediators as microorganisms. To find appropriate 
therapeutical targets without altering the immune status of the patient it is important 
to identify proteins and genes selectively upregulated by overventilation (Fig. 1.4). 
Gene arrays adressed to this question tagged such genes and identified proteins such 
as amphiregulin (65). 
Figure 1.3:  Putative mechanisms of mechanotransduction in VILI. Adopted from Reference 
(67). Activation of “stretch response elements” (SRE) via (A) mechanosensitive cation channels, 
calcium mobilisation and activation of the protein kinase C (PKC), (B) membrane disruption and 
calcium mobilisation, cfos and NFkB activation, (C) cytoskeletal structure with integrin mediated 
activation of mitogen-activated kinases and transcription factors. PLCγ = Phospholipase C γ; PIP2 
= Phosphatidylinositol-4,5-bisphosphate; IP3 = Inositol trisphosphate; DAG = Diacetylglycerol; 
MAPK = Mitogen-activated protein kinase; SAPK = Stress-activated protein kinase; NFκB = nuclear 
factor kappa-light-chain enhancer of activated B cells.
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1.1.2.6. Amphiregulin
Amphiregulin, a polypeptide growth factor which belongs to the epidermal growth 
factor family, is a ligand of the receptor tyrosine kinase Erb B1 (49). It promotes the 
growth of keratinocytes and fibroblasts, which may play a role in mast cell mediated 
lung fibrosis (286). Most amphiregulin studies address its participation in cancer, 
especially in breast and lung cancer (122; 159; 297). Apart from mechanical stress 
amphiregulin is also upregulated by oxidative stress (hyperoxia) (258; 284). 
Amphiregulin is a membrane-anchored protein which is cleaved by matrix-
metalloproteinases like ADAM 17 (a disintegrin and metalloproteinase), a process 
referred to as “shedding” (228). In its soluble form amphiregulin can bind to Erb B1, 
which autophosphorylates key tyrosine residues. These tyrosine phosphorylated sites 
allow proteins to bind through their Src homology 2 (SH2) domains and leads to the 
Figure 1.4:  Initiation of ALI by both microorganisms and overventilation of lung tissue. VILI-
specific genes, such as amphiregulin, and proteins may act as specific marker genes/proteins. VILI 
= ventilator-induced lung injury; TLR = Toll-like receptor; ALI = Acute lung injury. From Reference 
(270).
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activation of downstream signalling cascades including the RAS/extracellular signal 
regulated kinase (ERK) pathway, the phosphatidylinositide 3-kinase (PI3) pathway and 
the Janus kinase/Signal transducer and activator of transcription (JAK/ STAT) pathway. 
Activation of MAP kinases, PI3 and transcription factors has been demonstrated in cell 
culture experiments (55; 193; 266). In addition cell culture experiments demonstrated 
that mechanical stretch activates Erb B1 via amphiregulin shedding (193) and revealed 
amphiregulin release as a mediator of TNFα-induced IL8-secretion (45). 
1.2. Precision-cut lung slices (PCLS)
Organ slices have been used as an in vitro model for toxicological and biochemical 
studies for a long time. They represent an organ “mini-model” that closely resembles 
the organ from which it is prepared, with all cell types present in their original tissue-
matrix configuration. The production of organ slices has been benefited enviromentally 
by the introduction of precision-cut tissue slices. Earlier techniques using manual 
equipment suffered from a lack of reproducibility within the slices and a relatively 
limited viability (194). In 1980 Krumdieck et al. overcame this problem by introducing 
an automated, mechanical tissue slicer (131). It allowed the production of relatively 
thin (200-500 µm) and identical slices providing an appropriate supply with gas and 
nutrient exchange by diffusion. Originally established for the production of liver slices 
the technique was adapted to other tissues such as kidney, heart and lung.
The precision-cut lung slice technique was introduced by Stefaniak et al. in 1992 (248). 
Compared to the relatively compact liver tissue the lung parenchyma is much softer 
due to its function as a dynamic organ. Although lung slices have been used as an in 
vitro system before the precision-cut slice technique together with filling the lung with 
low melting point agarose prior to the slicing process, improved the quality of lung 
slices. 
The long-term maintenance of lung slices cultured in defined media was described 
shortly after by Siminsky et al. (237). 
1.2.1. PCLS from different species
PCLS can be prepared from different mammals. The first lung slices were prepared 
from rat lungs followed later by human lungs (77; 248). Human lung tissue can be 
obtained from lung donors or from cancer patients undergoing surgery. Since then 
the technique has been expanded to different species such as mice (208), hamsters 
(221), guinea pigs (218), rabbits (238), cattle (88), horses (279) and monkeys (120; 217). 
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1.2.2. PCLS as an in vitro model
Using PCLS as a model has many advantages. First, up to 50 slices can be prepared 
from one lung. This does not only save animals but also helps to reduce experimental 
error by internal controls and statistical pairing (217). In contrast to cell cultures the 
anatomical structure of the lung is preserved. That means that not only one or two 
cell types of the lung are studied but the complete variety of lung cells embedded 
in their normal extracellular matrix environment. This is especially of interest in the 
context of cell stretch. The role of the extracellular matrix (e.g. integrins) as a stretch 
sensor has been under discussion for some time now (46; 99; 119; 123; 185; 209; 264). 
The intact microanatomy also allows for auxotonic smooth muscle contraction which 
may be closer to the in vivo situation than other in vitro methods, such as isotonic or 
isometric contractions (217). Another advantage of the model is that it provides the 
opportunity to study physiological responses in the same model in different species. 
This could be particularly useful in regard to species differences between animals and 
humans (51; 217; 265). 
1.2.2.1. The use of PCLS in metabolism and toxicology 
Lung slices are a useful tool for studying lung metabolism and toxicology because of the 
speed and simplicity of slice preparation. Several slices from one lung may be studied 
simultaneously avoiding experimental variations and decreasing animal numbers. 
Toxicities of paraquat, 3-methylindole and 1-nitronaphthalene to rat PCLS were the first 
to be investigated by Price et al. in 1995 using potassium content and protein synthesis 
as viability parameters (207). Shortly after, the use of human PCLS was demonstrated 
by exposing them to the pulmonary toxicants acrolein and nitrofurantoin (77). Until 
today especially rat PCLS have been extensively used to study pulmonary toxicants 
and to some extend they have been compared with cell culture experiments (169; 207). 
In addition, the pulmonary metabolism and the resulting effect to enzyme activity 
has been studied in PCLS for xenobiotics such as 7-ethoxycoumarin, diesel exhausts 
or jet fuel (106; 140; 205). Table 1.1 summarises the use of PCLS in metabolism and 
toxicology. Another application is the use of PCLS to study pathological mechanisms 
after exposure to viruses, cytokines or metabolites (70; 88; 111; 125). 
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Table 1.1:   Metabolism and toxicological studies in PCLS.
Substance Species Process investigated (Reference)
[Ring-U-14C] Agaritine Rat, mouse Metabolism (208)
1-methylphenanthrene Rat GST activity, CYP1 induction/apoprotein-/
mRNA-levels, epoxide hydrolase activity (210; 
212; 213)
1-nitronaphthalene Rat Viability by protein synthesis, potassium content 
(207)
3-methylindole Rat Viability by protein synthesis, potassium content 
(207)
4-(methylnitrosamino)-1-(3-
pyridyl)-1-butanol
Hamster Metabolism (221)
4-(methylnitrosamino)-1-(3-
pyridyl)-1-butanone
Hamster Metabolism (221)
7-Ethoxycoumarin Rat, mouse, human Metabolism, metabolic clearance, metabolic 
viability (57; 58; 205; 208; 273)
7-Hydroxycoumarin Human, rat Metabolism, metabolic clearance (57; 58)
Acrolein Human, rat Viability by protein synthesis (77; 169)
Aroclor 1254 Rat mRNA expression of CYP forms, CYP1A 
induction (136; 206)
Arsenite Rat Immediate early gene expression (296)
Beclomethasone dipropionate Human Metabolism (181)
Benzo(a)pyrene Rat Induction of CYP forms, mRNA and apoprotein 
levels, DNA adducts, epoxide hydrolase activity 
(102; 103; 136; 206; 210-213)
Benzo(b)fluoranthene Rat CYP1 induction, mRNA and apoprotein levels, 
epoxide hydrolase activity, GST activity (210; 
212; 213)
Budenoside Human Metabolism (181)
Ciclesonide Human Metabolism (181)
Cigarette smoke Guinea pig Endothelial dysfunction (305)
Cotinine Rat CYP1A form induction (206)
Coumarin Rat Metabolism (205)
Dibenzo(a,h)anthracene Rat CYP1 induction, mRNA and apoprotein levels, 
epoxide hydrolase activity, GST activity (210; 
212; 213)
Dibenzo(a,l)pyrene Rat CYP1 induction, mRNA and apoprotein levels, 
epoxide hydrolase activity, GST activity (210; 
212; 213)
Diesel exhaust Rat Toxicity by DNA alterations, inflammatory 
response (140)
DNCB Mouse Ex-vivo lung functions (110)
Erucin Rat Modulation of pulmonary carcinogen-
metabolising enzyme system (101)
Fluoranthene Rat CYP1 induction, mRNA and apoprotein levels, 
epoxide hydrolase activity, GST activity (210; 
212; 213)
Fluticasone propionate Human Metabolism (181)
Jet Propulsion Fuel-8 Rat Toxicity by ATP content (106)
Lidocaine Human, rat Metabolism (57)
Methyltestosterone Rat Metabolic clearance (58)
Nicotine Rat CYP1A form induction (206)
Nitrofurantoin Human Viability by protein synthesis, NPSH (77)
Paraquat Rat Viability by protein synthesis, potassium content 
(207)
ß-naphthoflavone Rat mRNA expression of pulmonary CYP forms, 
CYP1A form induction (136; 206)
Sulphoraphane Rat Modulation of pulmonary carcinogen-
metabolising enzyme system (101)
Testosterone Human, rat Metabolism, metabolic clearance (57; 58)
TMA Mouse Ex-vivo lung functions (110)
Warfarin Rat Metabolic clearance (58)
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1.2.2.2. The use of PCLS in pharmacology
In 1995 Martin et al. introduced rat PCLS as a model for pharmacological studies of 
airways (153). Bronchoconstriction of single airways in response to mediators such as 
methacholine was measured and analysed using videomicroscopy. These studies were 
extended to different species (mice, human) and to various airway sizes addressing 
also peripheral airways (155; 304). The measurement of vasoconstriction was also 
established in PCLS (108). Besides responses to endogenous and exogenous stimuli, 
broncho- or vasoconstriction in PCLS has been compared to other in vitro models 
like the isolated perfused and ventilated mouse and rat lung (108; 152) or invasive 
pulmonary tests in vivo (110). PCLS have become an important ex vivo alternative to in 
vivo respiratory measurements of bronchoconstriction to allergens. For example, the 
immediate allergic response of the airways was assessed in lung slices of ovalbumin-
sensitised animals or in passively sensitised lung slices of naïve animals (303; 304). In 
connection with asthma bronchoconstriction in PCLS has been used as a model to 
study clinical properties of β2-adrenoceptor-agonists (53; 182; 253) or PDE4-inhibitors 
(151).
1.2.2.3. The use of PCLS in signalling mechanisms
Lung slices have been successfully employed in the study of mediators and 
mechanisms involved in airway contraction (133; 134; 152; 155; 172; 200; 246; 251; 
303; 304). Furthermore, calcium signalling in smooth muscle cells of the airways can 
be studied (12). Besides mechanistic investigations of bronchoconstriction PCLS have 
also become a valuable tool for studying pathomechanisms of vascular diseases like 
pulmonary hypertension (191; 245; 247). PCLS also provide a convenient method to 
study local immune reactions of biologically active agents (111).
1.3. Experimental models
1.3.1. Models of lung toxicity and metabolism
In vivo studies of lung metabolism and toxicology are complicated because of the 
relative small mass of lung tissue and an enormous blood flow. This makes it difficult 
to measure arteriovenous differences of most circulating metabolites. Systemic 
influences such as infiltration of phagocytic cells or formation of immune complexes 
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at the site of injury aggravate the complexicity of such in vivo studies (81). For drug 
development it is indispensable to use experimental animals to determine the major 
toxicities of a new compound, since only in an intact organism the complex interplay 
of metabolism and drug exposure can be examined.
Apart from the in vivo methods many in vitro systems have been developed. The 
isolated perfused mouse or rat lung maintains the lung as a whole organ. The lung is 
perfused with whole blood or substituted media via the pulmonary artery of artificially 
ventilated lungs. Uptake, metabolism and disposition can be examined as well as the 
interaction of exogenous and endogenous substances and their interactions (164; 302). 
Other in vitro studies include lung subcellular fractions, homogenates, homogenous 
populations of isolated or cultured cells, and mixed cell organ cultures.
Different cellular models from human pulmonary origin have been developed as 
experimental model to investigate the effect of xenobiotics on human lung (309). 
The best characterised and most widely used model probably is the adenocarcinoma 
A549 cell line, derived from pneumocytes type II, and the pulmonary adenocarcinoma 
NCI-H322, derived from bronchiolar Clara cells (6; 35). Although these cell lines express 
only a limited number of the phase I and phase II enzymes involved in detoxification 
or bioactivation, especially the A549 cells are considered to be a useful in vitro model. 
However, the use of lung tissue slices has always been viewed as an appropriate 
alternative to whole lung or cell culture models, even before the precision-cut lung 
slice technique (81). Especially the absence of cell-cell and cell-matrix connections in 
cell culture is an issue and may result in a loss of differentiated functions. Therefore 
in vivo metabolism may be mimicked by lung slices, where the number of animals 
required is decreased. 
1.3.2. Models of allergy and asthma
1.3.2.1.  In vivo asthma models
Studying asthma in human asthma patients is only possible to a certain extent. 
Bronchoalveolar lavage fluid and bronchial biopsies can be analysed in asthmatic 
patients after allergen challenge. Experiments of such kind have given some insight 
into cells and mediators playing a role in asthma (27; 184; 290). However, clinical 
settings can only reflect parts of asthma, bronchoconstriction for example can only be 
determined indirectly by measuring the FEV1 (forced expiratory volume in 1 second). 
Aside from being unpleasant such experiments are frequently some risk for the patient.
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One class of in vivo models of asthma is represented by animals with naturally 
occurring recurrent airway obstruction (217). Cats for example spontaneously 
develop eosinophilic airway inflammation and airway hyperreactivity, the so called 
feline asthma. It is characterised by dyspnea, wheezing, cough and hyperplasia of 
submucosal glands, proliferation of goblet cells and smooth muscle hypertrophy 
(174). Exposure to inhaled aeroallergens showed allergen-specific IgE-production, 
airway hyperreactivity, eosinophilia and a Th2-cytokine profile in the BAL (187). 
Pathophysiological studies suggest important similarities between human and feline 
responses to inhaled allergens which need to be further examined (187; 216). 
In principal, ponies can develop heaves, also characterised by recurrent airway 
obstruction, when they are housed in barns and fed with hay (64). It is featured by 
lower airway inflammation, bronchoconstriction and mucus accumulation (141). 
Clinical signs alternate with remission periods, which is comparable to some forms of 
industrial asthma in which hyperreactivity occurs only in acute airway obstruction (64). 
Basenji-Greyhound crossbred dogs show a nonspecific bronchial hyperreactivity 
to stimuli like metacholine or citric acid without allergen challenge. Being a main 
characteristic of human asthma this airway hyperresponsiveness makes them a useful 
tool to study specifically that part of asthma (113; 190).
Besides naturally occurent recurrent airway obstruction and AHR without provocation 
there are several models of airway obstruction and AHR after allergen sensitisation 
and challenge. Most models represent certain aspects of asthma. The range of animal 
models available is vast, with the most popular models being rodents, such as rats 
and mice, and guinea pigs. Compared with other models these are easy to handle 
and relatively cost effective (315). Rats have been used to study allergen-induced 
bronchoconstriction, eosinophilic inflammation, LPR, AHR and airway remodeling. 
Mice are in general an attractive model because of their well known immune system 
and the availibility of knock-out or transgenic strains. After sensitisation mice develop 
eosinophilia, AHR, increased IgE-levels, mucus hypersecretion and sometimes airway 
remodeling. Nevertheless the discrepancy in immunology and anatomy between 
mice and humans must be recognised (315). Airway anatomy and the response to 
inflammatory mediators of the guinea pig are similar to humans (220). It is characterised 
by a direct anaphylactic bronchoconstriction upon allergen challenge, LPR, AHR and 
an inflammatory response comparable with the human situation (220). 
Some larger mammalian models using dogs, pigs, rabbits and sheep have been 
developed (315). Every one of them may address some aspects of human asthma more 
appropriate than the mouse model, but they also differ from humans in many ways 
and are extremely costly, with very few probes available (220; 315). The sheep model 
represents many pathophysiological properties of human allergic airway diseases. 
Sheep with a natural sensitivity to ascaris suum show an immediate EAR and a 6 to 8 
hours delayed LPR after challenge with this antigen (4; 5; 244). AHR occurs mostly if 
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EAR and LPR were present before and especially the possible use of human relevant 
allergens like house dust mites makes this model promising (24; 137). Recently, even a 
model of airway remodelling in sheep has been developed (243). 
1.3.2.2.  In vitro asthma models
In vitro models concentrate on single physiological parameters of asthma. Most in vitro 
models involve small mammalian species to provide easy handling and cost efficiency. 
The closest ex vivo model to study allergic asthma may be the isolated perfused mouse, 
rat or guinea pig lung (108; 152; 234), where bronchoconstriction, vasoconstriction, 
edema and gas exchange can be investigated. Such systems allow better control, but 
do not save animals by using one lung per experiment. 
Simplification of the whole lung can be achieved by tissue preparations cultured in 
organ baths (25; 124; 127; 202; 225; 231; 274). These preparations include parenchymal 
strips, isolated trachea or bronchi and vessels. They allow the examination of broncho- 
and vasoconstriction as well as smooth muscles. Since the tissue is separated from the 
surrounding tissue the comparison with the in vivo situation has remained difficult.
1.3.3. Models of physical stimuli
1.3.3.1. Clinical studies of mechanical ventilation
Acute respiratory distress syndrome was first described in 1967 (287). Since then a 
number of phase III, placebo-controlled clinical trials have been completed which 
had a significant impact on understanding the pathogenesis of ALI and ARDS, as well 
as providing evidence-based guidelines for better treatment of patients. Table 1.2 
summarises some clinical studies and their outcome. 
The possibility of ventilator-associated lung injury was first considered in the 1970 
(288). Since then the most appropriate method of mechanical ventilation has been 
controversial. A variety of assumed lung protective strategies were investigated in 
clinical trials. The only intervention to date that has clearly shown a benefit in survival 
has been the 6 versus 12 kg/ml predicted body weight tidal volume trial which 
reduced mortality from 40 % to 31% (2). Follow-up studies with an increased PEEP to 
further improve the clinical outcome did not improve mortality (29). Several promising 
pharmacological therapies including surfactant, nitric oxide, glucocorticoids and 
lysofylline, have been studied in patients with acute lung injury and the acute 
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respiratory distress syndrome. However, none of these pharmacological treatments 
reduced mortality (38). Investigation of cytokines in clinical studies showed that 
ventilator settings influence pulmonary cytokine levels. Ranieri et al. found lower 
cytokine levels in BAL fluid of patients ventilated with low tidal volumes, which is 
consistent with the ARDSnet trial that found lower plasma IL-6 levels in the low tidal 
volume group (2; 215). In longitudinal studies higher cytokine levels were correlated 
with a worsened outcome (163). 
Table 1.2:   Different clinical trials of ARDS. 
Description of trial Number of 
patients 
Year Outcome Reference
Extracorporeal membrane 
oxygenation
90 1979 No change in mortality (312)
High-frequency jet 
ventilation
309 1983 No change in mortality (33)
Prophylactic positive end-
expiratory pressure (8cm of 
water)
92 1984 No benefit for patients at risk 
for ARDS
(197)
Glucocorticoids (during 
acute phase)
87 1987 No benefit (21)
Extracorporeal removal of 
carbon dioxide
40 1994 No change in mortality (173)
Surfactant 725 1996 No benefit (8)
“Open-lung” approach (PEEP 
set by PVC)
53 1998 Decreased 28-day mortality 
but not in-hospital mortality
(7)
Low tidal volumes 120 1998 No benefit for patients at risk 
for ARDS
(250)
Low tidal volumes 116 1998 No change in mortality (28)
Reduced tidal volumes 52 1999 No change in mortality (30)
Low tidal volumes 861 2000 Mortality reduced from 40% 
to 31%
(2)
Lisofylline 235 2002 No benefit (1)
Higher vs. lower level of 
PEEP
549 2004 No change in mortality (29)
Glucocorticoid trial for 
persistent ARDS
180 2006 No change in mortality (249)
Fluid and catheter treatment 
trial
1000 2006 No differences in clinical 
outcomes
(291; 294)
Low tidal volumes, 
recruitment maneuvers, 
high PEEP
983 2008 No change in mortality (162)
1.3.3.2.  In vivo models 
In vivo models of ALI and mechanical ventilation have been studied in a variety of 
animals. Mice, rats, rabbits, dogs, sheep and pigs are most widely used. Most animal 
models of ALI are based on reproduction of human risk factors for ARDS, such as 
sepsis, lipid embolism, acid aspiration and ischemia reperfusion of pulmonary or distal 
vascular beds (158). Each of these risk factors has been tried to be reproduced in a 
variety of animals. The differences between each model and human lung injury as well 
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as the major advantages and disadvantages are outlined in Table 1.3. Models of ALI 
provide the opportunity to study mechanical ventilatory strategies in diseased lungs, 
known as two-hit models. Lots of studies dealt with the effect of PEEP, volume and 
pressure limits, and high frequency modes (16; 94; 280). Apart from the induction of 
ALI by risk factors, VILI can also be elicited solely by high tidal volume ventilation (298). 
Less complex ex-vivo models of VILI are represented by isolated lungs. This model is 
well established for rat (48; 219; 261; 262; 292) and mouse lungs (13; 43; 107; 283). Here, 
the experimental design focuses on ventilatory strategies alone (13; 43; 48), frequently 
in comparison with LPS (107; 219; 262; 292).
In almost all studies, cyclic overstretch increased alveolar levels of IL-8 or its rodent 
equivalent MIP-2. Depletion of Neutrophils in the lungs attenuated the IL-8 increase 
resulting in a model of less severe VILI (95). Wilson et al. related neutrophil recruitment 
in mice ventilated with high tidal volumes to increased levels of TNFα and MIP-2 in the 
BAL (298; 299). The critical role of neutrophil sequestration in mice was confirmed by 
Belperio et al. and connected to CXCR2 after a ventilation strategy of high peak pressure 
and stretch (19). IL-1β, IL-6 and to some extent TNFα were also induced in many studies 
(95). In general, cytokine levels seem to be higher with larger tidal volumes or absent 
PEEP or when animals are concomitantly subjected to other injurious strategies such 
as hyperoxia (13). Injured lungs seem to be far more susceptible to VILI than healthy 
lungs.
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Table 1.3:   Animal models of lung injury. From reference (158).
Model (Reference) Similarities with ARDS Differences with ARDS Technical Issues
Oleic acid (233) Acute and repair 
phases with similar 
histopathological and 
physiological features to 
human ARDS
Only a fraction of 
human ARDS is caused 
by fat embolism, 
does not model the 
physiopathology of septic 
ARDS
Good 
reproducibility 
Requires 
intravenous 
injection of oleic 
acid, which can 
be difficult in 
small animals
LPS (295) Neutrophilic 
inflammatory response 
with increase in 
intrapulmonary cytokines
The changes in alveolar-
capillary permeability are 
mild
Very reproducible
Acid aspiration (167) Disruption of the alveolar/
capillary barrier with 
neutrophilic infiltration
Humans aspirate gastric 
contents, not pure acid
Very reproducible 
Narrow 
difference 
between 
injurious and 
noninjurious 
doses
Hyperoxia (80) Acute phase of epithelial 
injury and neutrophilic 
infiltration followed by 
type II cell proliferation 
and scarring
In normal human lungs, 
100% oxygen has not 
induced lung injury; 
it is unclear whether 
hyperoxia is involved in 
the pathogenesis of ARDS
Good 
reproducibility 
Requires special 
equipment to 
administer and 
monitor the 
desired gas 
concentrations
Bleomycin (171) Acute inflammatory injury 
followed by reversible 
fibrosis
No formation of 
hyaline membranes, 
physiopathological 
relevance unclear
Good 
reproducibility
Saline lavage (67; 135) Depletion of surfactant 
Decreased lung 
compliance Impaired gas 
exchange
Without an additional 
stimulus, there is 
minimal impairment of 
permeability and little 
PMN recruitment
Animals must 
be anesthetized, 
intubated, 
and ventilated 
throughout the 
procedure and 
afterwards
Pulmonary ischemia/
reperfusion (229)
Increase in pulmonary 
vascular permeability 
PMN infiltration
The injury is usually 
hemorrhagic
Requires complex 
animal surgery
Nonpulmonary ischemia/
reperfusion (129)
Increased microvascular 
permeability and PMN 
sequestration in the lungs
The injury is mild, and the 
inflammatory component 
mostly limited to the 
interstitium
Requires complex 
surgery
Intravenous bacteria (56) Interstitial edema, 
intravascular congestion, 
PMN sequestration
Minimal neutrophilic 
alveolitis; no hyaline 
membrane formation
Important 
biological 
variability
Intrapulmonary bacteria 
(78)
Increased permeability, 
interstitial edema, 
neutrophilic alveolitis
Positive cultures rare in 
early ARDS
Important 
biological 
variability
Peritonitis (157) Increased permeability, 
variable degrees of 
neutrophilic alveolitis
Minimal hyaline 
membrane formation
Biological 
variability, lethal 
dose close to 
injury dose
Cecal ligation and 
puncture (281)
Increased permeability, 
variable neutrophilic 
alveolitis
Minimal hyaline 
membrane formation
Biological 
variability, 
surgery required
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1.3.3.3.  In vitro models
In vitro models of mechanostimulation can be divided in (i) stretching of lung tissue 
preparations, and (ii) stretching of lung cells.
1.3.3.4. Stretch of lung tissue preparations
Lung parenchymal strips have been widely used to investigate airway mechanics (52) 
and to measure dynamic properties of lung parenchyma (310). The strips can also be 
stretched. To this end, the tissue is attached to a clip on each side of the strip to stretch 
the strip vertically in an organ bath (255). Tanaka et al. used the technique to measure 
viscoelastic properties of rat lung strips dependent on maturation (255). Others found 
different magnitudes of stretch affecting elastance, tissue damping and tension 
(230). Using dog parenchymal strips Navajas et al. investigated the effect of nonlinear 
elasticity to the dynamic behaviour of the lung parenchyma (180). Investigations of 
such tissue preparations help describing parameters and boundary conditions to 
model tissue behaviour. Although the strips include a relatively intact microanatomy, 
the measured response is difficult to interpret with respect to the uniaxial application 
of stretch and because of the possible unequal fixation of the tissue. In addition it 
is complicated to set the applied stretches in relation to the whole organ. Thus the 
model is not useful to investigate biological parameters like cytokines.
1.3.3.5. Stretch to lung cells
Several approaches deal with the mechanostimulation of cells. They can be categorised 
in terms of the applied stretch or physical grade of the stretch applied. Application 
forms of stretch comprehend hydrostatic or direct platen contact, longitudinal in-plane 
uni- and biaxial stretch, bending and fluid shear stress (31). Cells are stretched using 
elastic biocompatible carrier membranes. By determining the membrane deformation 
the applied strain can be translated into tissue elongation (276). Amongst a variety of 
custom made mechanical devices, the Flexercell system is the best established (10; 15; 
36). Cells are grown on flexible bottom culture plates which allow up to 30% elongation. 
A vacuum is used to apply a defined controlled static or dynamic deformation. A 
method that applies stretch directly to cells is the magnetic twisting stimulator (63). 
Ferromagnetic beads are coupled to the cells via the integrin receptor and twisted in a 
magnetic field. Twisting the integrin receptors directly affects the cytoskeleton, which 
is attached to the integrin receptor. However, this technique has been mostly applied 
to vascular endothelial cells addressing cell stiffness (42; 148).
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Primary rat alveolar epithelial cells have been used extensively in cell stretch devices. 
Many studies have been done with isolated rat alveolar type II (AT II) cells stretched 
in mechanical devices like the Flexercell system. As soon as isolated AT II cells are 
cultured they loose their specific markers and start to differentiate. After 5 days in 
culture they have lost the AT II marker molecules and look more similar to AT I cells. 
Accordingly experiments with AT II cells have to be done in the first days culturing 
and take the loss of already modified cells. In AT II cells apoptosis and necrosis is 
increased after application of high amplitude mechanical stretch (97). The apoptosis 
is reduced by NO addition which is assumed to be released by alveolar macrophages 
(71). In addition, surfactant secretion is increased via the PGI2-cAMP axis by cell 
surface stretching (224). This surface stretch seems to be dominated by the attached 
basal surface. In contrast to surface stretch induced by cyclical stretch, tonically held 
stretches lead to plasma membrane expansion via lipid insertion (75). Furthermore the 
inflammatory response in stretched cells was addressed by several studies. An increase 
of reactive oxygen species, namely superoxide, was observed and Hammerschmidt 
et al. found proinflammatory mediators to be induced (39; 98). In addition ERK 1 and 
2 were induced in stretched cells presumably by activation of the EGF receptor and 
G proteins (55). To address barrier disruption and edema formation the Na/K-ATPase 
was investigated in AT II cells. The created transepithelial Na+ gradient is important 
to keep fluid from the alveolar space. Na/K-ATPase activity was also increased by 
cyclic stretch (76). Otherwise cell integrity was mainly investigated in differentiated 
AT II cells, that may or may not represent AT I cells. Tschumperlin et al. examined the 
characteristics of stretch related to deformation-induced injury. Accordingly the degree 
of injury was greatest with cyclically stretch at high amplitudes (268). Paracellular 
permeability also seems to be increased by stretch in AT I cells (36). In agreement 
with the increased permeability Cavanaugh et al. found a disruption of tight junction 
structures and cell-cell attachment potentially due to an intracellular ATP reduction 
and actin perturbation (37). A variety of cell stretch experiments has also been done 
in immortalised cell lines especially in A549 cells. Adenocarcinoma A549 cells, derived 
from human type II pneumocytes, are well characterised and widely used as a model 
from human pulmonary origin. In stretched A549 cells particular regard has been paid 
to the investigation of inflammatory responses. The stretch-induced upregulation and 
production of IL-8 was investigated in many studies and seems to be associated with 
the upregulation of AP1 and NFkB (145; 282). Other proteins found to be involved are 
JNK, NIK, protein kinase C, Src protein tyrosine kinase, SAPK and p38 (66; 145; 214; 307). 
A synergistic effect of mechanical stretch and LPS on IL-8 induction has been reported 
by Ning et al. (186). 
All of these models are applicable to a variety of questions concerning stress in the 
lungs. However, stretching of PCLS in a biaxial direction provides a link between in 
vivo models and cell culture models, which maintains the microanatomy with the 
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extracellular matrix on the one hand, and the cell culture-like handling on the other 
hand.
1.4. The bioreactor
The bioreactor was first described in 2008 by Schumann et al. as a pressure-driven 
strain-applicator which uses spherical deflection of a carrier membrane transmitting 
a well-defined tensile strain to a biological sample placed on top of it (232). The 
bioreactor consists of two similar vertically arranged cylindrical rigid chambers which 
are separated by a circular elastic membrane fixed in a membrane holder. Deflection of 
the carrier membrane is achieved by cyclic increase of pressure to the chamber below 
the membrane (Fig 1.5). Therefore, the membrane is distended with a biaxial tension 
which was used in a cell stretch model before (300). Combination of the bioreactor 
with PCLS seems to be a useful model to investigate lung stretch in relatively intact 
lung tissue in vitro, which will be discussed in detail in this work.
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Figure 1.5:  Schematic of the bioreactor which consists of the lower (1) and the upper chamber (2), 
separated by the membrane complex. A membrane (3) is fixed in the membrane holder (4). The 
upper chamber is equipped with a glass window to allow direct observation (5). Deflection of the 
membran is provided by volume input through an inlet in the lower chamber (6). From reference 
(232). 
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2. Aim of the study
Precision-cut lung slices represent an ideal link between in vivo models and cell culture. 
The model maintains a relatively intact microanatomy, the diversity of cell types of the 
lung and its extracellular matrix under cell culture conditions. The aim of this study was 
to use PCLS as a model to study different types of stress.
Bronchoconstriction caused by chemical allergens, such as TMA and DNCB, was 
investigated in PCLS and compared to invasive lung function measurements. The 
objective was to identify PCLS as an easy, reliable alternative method to measure lung 
function changes ex vivo. 
To study mechanical stretch of lung tissue, a new model was developed to stretch 
PCLS in a bioreactor. It was our aim to investigate occurring forces on alveolar level and 
molecular stretch marker, such as amphiregulin.
PCLS from sheep, who are mammalians and therefore closer to humans than rodents, 
were established as a new model. To characterise them, it was our aim to identify the 
airway response to unspecific stimuli, such as methacholine. Furthermore, PCLS were 
prepared from adult and premature sheep to investigate age-dependent differences.
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3.1. Material
3.1.1. Instruments
Instrument Manufacturer
Agilent Bioanalyser Agilent Technologies, Santa Clara, USA
Beam splitter Trim Scope, La Vision, BioTec, Bielefeld, 
Germany
Bench Laminair HB2448 Heraeus, Hannover, Germany
Bioreactor Custom made by the group of Prof. Guttmann, 
Freiburg, Germany
Coring Tool Black & Dekker battery operated screwdriver 
+ self-made coring device
Digital camera (multi photon microscope) Imager QE, La Vision BioTec, Bielefeld, 
Germany
ELISA reader GENios, Tecan, Crailsheim, Germany
GeneChip® Rat Exon 1.0 ST Array Affimetrix, Santa Clara, USA
Heraeus Fresco 17 Centrifuge Heraeus, Hannover, Germany
Heraeus Multifuge 3SR+ Centrifuge Heraeus, Hannover, Germany
Incubator Heraeus, Hannover, Germany
Inverted microscope DMIRB and DMIL Zeiss, Oberkochen, Germany
Krumdieck Tissue Slicer Alabama research and development, 
Munford, USA
Leica MZ FLIII Zeiss, Oberkochen, Germany
Light Cycler 480 Roche, Mannheim, Germany
Meta detector LSM 510 Meta, Zeiss, Jena, Germany
Nano Drop 1000 Fisher Scientific, Wilmington, USA
Pressure transducer Scientific Instruments, Aachen, Germany
Ti:Sa femtosecond laser Coherent, Dieburg, Germany
Video camera JAI PROTEC JAI20040, JAI Pulnix, Alzenau, Germany
Video camera Leica Zeiss, Oberkochen, Germany
Video camera Visicam 1300 and 640 Visitron Systems, Munich, Germany
Waterbath WP10 P-D Indutriegesellschaft mbH, Dresden 
Germany
3.1.2. Software
Software Manufacturer
GraphPad Prism 5 Software GraphPad, San Diego, CA, USA
Imspector software La Vision, BioTec, Bielefeld, Germany
JMP 7 SAS Campus Drive, Cary, USA
Light Cycler 480 software Roche, Mannheim, Germany
Optimas 6.5 Optimas Corporation, Bothell, USA
R2 Team 2006, Vienna, Austria
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3.1.3. Chemicals
Substance Manufacturer
5-Hydroxytryptamin (Serotonin) Sigma, Deisenhofen, Germany
5x first strand buffer Invitrogen, Karlsruhe, Germany
Actinomycin D Sigma, Deisenhofen, Germany
Apicidin Sigma, Deisenhofen, Germany
CaCl2 Sigma, Deisenhofen, Germany
Collagenase H Roche, Mannheim, Germany
Cycloheximide Sigma, Deisenhofen, Germany
Cytochalasine D Sigma, Deisenhofen, Germany
Dexamethasone Sigma, Deisenhofen, Germany
Dimethyl sulfoxide (DMSO) Merck, Darmstadt, Germany
Dinitrochlorobenzene (DNCB) Sigma, Deisenhofen, Germany
DNTPs Peqlab, Erlangen, Germany
5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole 
(DRB)
Sigma, Deisenhofen, Germany
Dithiothreitol (DTT) Invitrogen, Karlsruhe, Germany
Endothelin-1 Bachem, Weil, Germany
Ethanol Merck, Darmstadt, Germany
Formic acid Merck, Darmstadt, Germany
Genistein Sigma, Deisenhofen, Germany
Glucose Sigma, Deisenhofen, Germany
Glutamine PAA Laboratories, Pasching, Austria
HEPES Sigma, Deisenhofen, Germany
Histamine Sigma, Deisenhofen, Germany
Imipramine Sigma, Deisenhofen, Germany
iso-propanol Merck, Darmstadt, Germany
KCl Sigma, Deisenhofen, Germany
Lanthanum (III) chloride Sigma, Deisenhofen, Germany
LightCycler 480 SYBR Green I Master Roche, Mannheim, Germany
Low melting point agarose Gerbu, Gaiberg, Germany
Lipopolysaccharide (LPS) Sigma, Deisenhofen, Germany
Leukotriene D4 (LTD4) Biomol, Hamburg, Germany
Minimal essential medium (MEM) Aminoacids PAA Laboratories, Pasching, Austria
Minimal essential medium (MEM) Vitamins PAA Laboratories, Pasching, Austria
Metacholine Sigma, Deisenhofen, Germany
Methanol Merck, Darmstadt, Germany
MgSO4 Sigma, Deisenhofen, Germany
ML-7 Biomol, Hamburg, Germany
(3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT)
Sigma, Deisenhofen, Germany
NaCl Sigma, Deisenhofen, Germany
NaH2PO4 Sigma, Deisenhofen, Germany
NaHCO3 Sigma, Deisenhofen, Germany
Oligo dT primer 12-18 Invitrogen, Karlsruhe, Germany
PCR grade H2O Roche, Mannheim, Germany
Penicillin/Streptomycin PAA Laboratories, Pasching, Austria
PP2 Calbiochem, Bad Soden, Germany
Primer MWG, Ebersberg, Germany
Propidium iodide Invitrogen, Karlsruhe, Germany
Rnase free water Ambion, Darmstadt, Germany
Rnase Out Invitrogen, Karlsruhe, Germany
Ruthenium Red Sigma, Deisenhofen, Germany
Sodium pyruvate PAA Laboratories, Pasching, Austria 
Sphingosine-1-Phosphate Biomol, Hamburg, Germany
SuperScript II Reverse Transkriptase Invitrogen, Karlsruhe, Germany
Trimellitic anhydride (TMA) Sigma, Deisenhofen, Germany
U46619 Cayman, Ann Arbor, Michigan, USA
Y27632 Tocris distributed by Biozol, Eching, Germany
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3.1.4. Kits
Kit Manufacturer
LIVE/DEAD viability/cytotoxicity kit Invitrogen, Karlsruhe, Germany
NucleoSpin RNA II Macherey-Nagel, Düren, Germany
3.1.5. Solutions
3.1.5.1. Slicing medium
CaCl2    1.8 mM
MgSO4   0.8 mM
NaH2PO4  1 mM
KCl    5.4 mM
NaCl    116.4 mM
Glucose   16.7 mM
NaHCO3   26.1 mM
Hepes    25.17 mM
3.1.5.2. Incubation medium
CaCl2     1.8 mM
MgSO4    0.8 mM
NaH2PO4   1 mM
KCl     5.4 mM
NaCl     116.4 mM
Glucose    16.7 mM
NaHCO3    26.1 mM
Hepes     25.17 mM
Sodium pyruvate  1 mM
50 x MEM Amino acids 20 ml/l
100 x MEM Vitamins  10 ml/l
Glutamine   2 mM
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3.1.5.3. Double-concentrated incubation medium
Salts and additional substances were solved in half of the usual amount of Milli Q H2O. 
3.1.5.4. Agarose solution
Agarose was dissolved double-concentrated in Milli Q H2O and mixed with the same 
amount of double-concentrated incubation medium at 37°C. 
3.1.6. Animals
The animal experiments were approved by the local ethic committee (Landesamt für 
Natur, Umwelt und Verbraucherschutz, Nordrhein-Westfalen).
3.1.6.1. Rats
Female Wistar rats (approximately 300g) were obtained from Harlan Winkelmann 
(Borchen, Germany) and Janvier (Le Genest Saint Isle, France). Rats were maintained 
on laboratory food and tap water ad libitum in a regular 12h dark/light cycle at an 
ambient temperature of 22 °C. Acclimatization period was at least 7 days before use.
3.1.6.2. Mice
Mice were sensitised with TMA or DNCB by a standard sensitisation protocol and 
obtained by the group of A. Braun (ITEM, Hannover, Germany). The sensitisation 
protocol is illustrated in Figure 3.1.
3.1.6.3. Sheep
Lungs from sheep were obtained from our collaboration partner B. Kramer (Dept. of 
Pediatrics, Academisch ziekenhuis Maastricht, Maastricht, Netherlands). 
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3.1.7. Anaesthesia
Pentobarbital solution (Narcoren) was purchased from Merial (Hallbergmoos, 
Germany). 
3.2. Methods
3.2.1. Precision-cut lung slices
3.2.1.1. Preparation of rat lung slices
PCLS were prepared as previously described (153; 218) with the following modifications. 
After injection of 250 mg/kg pentobarbital the trachea was cannulated and the animals 
exsanguinated by cutting the vena cava inferior. Through the cannula, the lung was 
filled with a low melting-point agarose solution. After solidifying of the agarose on ice 
for 15 minutes the lobes were separated. Tissue cores were prepared with a rotating 
Figure 3.1:  Sensitisation protocol for actively sensitised mice with the chemicals TMA and DNCB. 
Animals were sensitised on days 0, 1 and 2 and boosted on day 8. Early allergic response (EAR) was 
performed on day 21 followed by airway hyperresponsiveness (AHR) on day 22. TMA = trimellitic 
anhydrate, DNCB = 2,4-dinitrochlorobenzene, AOO = acetone olive oil, DOO = DMSO olive oil, Mch 
= methacholine, EAR = early allergic response, AHR = airway hyperresponsiveness. From reference 
(110).
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sharpened metal tube. The cores were cut into 200 (physiological experiments) or 400 
(stretching experiments) µm-thick slices with a Krumdieck tissue slicer. Subsequently, 
the PCLS were incubated at 37°C in a humid atmosphere in minimal essential media 
supplemented with penicillin (100 Units/ml) and streptomycin (0.1 mg/ml). The pH-
value was adjusted to 7.2. To remove cell debris and the agarose, medium was changed 
every 30 minutes during the first 2 hours after slicing and every 60 minutes for the 
following 2 hours. Afterwards medium was changed every 24 hours.
3.2.1.2. Preparation of mouse lung slices
Mice were anesthetised with 200 mg/kg pentobarbital solution. PCLS were prepared 
as rat PCLS with the following modifications. After solidifying of the agarose-filled lung 
lobes on ice, the lobes were separated and embedded in 3 % agarose in cryotubes. The 
embedded lung lobes were solidified and cut into 220 µm thick slices with a Krumdieck 
tissue slicer.
3.2.1.3. Preparation of sheep lung slices
Sheep lung lobes were obtained from adult and newborn sheep after undergoing 
mechanical ventilation experiments. The lobes were filled with a 1.5 % low melting 
point agarose solution via the main bronchus. The lobe was cut into 1 cm thick plates, 
from which tissue cores around the airways were prepared. The cores were cut into 
220 µm thick slices with a Krundieck tissue slicer.
3.2.2. Viability of PCLS
3.2.2.1. Measurement of MTT-reduction
The capability of PCLS to reduce MTT (3-[4,5-Dimethylthiazol-2-yl]-2,5-
diphenyltetrazolium bromide) is dependent on mitochondrial activity and was used as 
a parameter of viability. PCLS were transferred into 24-well-plates (one PCLS per well) 
and incubated with 0.7 mg/ml MTT for 15 minutes. Subsequently, the supernatant 
was removed and the slices were lysed in 200 µl i-propanol/formic acid (95/5) for 20 
minutes. 100 µl of the supernatant was transferred into 96-well microtiter plates. The 
reduced MTT was measured spectrophotometrically at 550 nm.
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3.2.2.2. Live-Dead staining with propidium iodide
Confocal microscopy was used to assess the viability of stretched PCLS. Propidium 
iodide was used to stain nuclei of lysed cells (dead stain). PCLS were incubated with 
4 µg/ml propidium iodide for 2 min. External dye was removed by washing the PCLS 
thrice. The fluorescent dye was excited at 543 nm with a helium-neon laser. Emission of 
propidium iodide was detected with a meta detector adjusted to a detection window 
of 552-627 nm (red staining).
To localise the nuclei autofluorescence of the PCLS (green) was recorded seperately 
(excitation at 488 nm with an argon laser / emission with a bandpath filter of 505-
550 nm). Pictures are shown as an overlay.
3.2.2.3. Live-Dead staining with multi-photon microscopy
Viability of stretched PCLS was also determined by LIVE/DEAD viability/cytotoxicity 
assay visualised with multi-photon microscopy. PCLS were incubated with 5 µM Calcein 
AM (acetomethylester of calcein, live staining) and 10 µM ethidium homodimer (dead 
staining) for 30 minutes and then washed to remove external dye. The fluorescent 
dyes were excited at 800 nm with a Ti:Sa femtosecond laser, which laser beam was split 
up into 64 individual beams. The PCLS was simultaneously excited and scanned and 
the images were aquired using a digital camera. Emission of calcein AM was detected 
with an emission filter at 475-525 nm staining living tissue (cytoplasm, green) while 
ethidium homodimer, staining the nuclei and therefore marking dead cells (red), 
was detected at 600-650 nm. Emission of calcein AM and ethidium homodimer was 
recorded separately and is shown as an overlay.
3.2.2.4. Videomicroscopy of broncho-/ vasoconstriction
PCLS for videomicroscopy were selected by comparable airway or vessel size within 
the species (sheep respectively mice) and cultured in 24-well-plates (one slice per 
well). Every PCLS was covered with 1 ml medium and the PCLS was fixed with a nylon 
thread attached to a platinum wire. The 24-well-plate was positioned on the stage of 
an inverted microscope and recorded by a digital camera. Only completely relaxed 
airways were selected for the experiments. The area of the airway or the vessel was 
defined as 100 % and constriction was measured as percentage decrease to the initial 
area. A control image was taken before addition of the mediator and frames were 
recorded every 5 or 30 seconds for 5, 10 or 30 minutes (dependent on the study).
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3.2.3. Gene array
Gene array experiments were accomplished by the group of B. Denecke (IZKF Biomat, 
RWTH Aachen, Germany).
3.2.3.1. RNA-Extraction
Frozen PCLS were powdered among liquid nitrogen cooling. Total RNA was isolated 
using the NucleoSpin RNA II Kit according to the manufacturers instructions. RNA 
quality was determined using the RNA 6000 Nano Assay (Agilent Bioanalyser) and 
quantity was assessed using the Nano Drop 1000.
3.2.3.2. Microarray
All further processing of the total RNA (300 ng RNA) was performed according to the 
GeneChip Whole Transcript (WT) Sense Target Labeling Assay Manual (Affymetrix). The 
fragmented labelled sample was hybridized to an Affymetrix GeneChip® Rat Exon 1.0 
ST Array (~1 million probe sets covering 850000 exon clusters). The microarray analysis 
was performed using Bioconductor (86) packages under R2. Gene induction is given 
as fold increase of the log 2 values in the PCLS in comparison to the log 2 values of 
untreated lung tissue. 
3.2.4. Real-Time PCR
3.2.4.1. RNA-Extraction
Frozen PCLS were powdered among liquid nitrogen cooling. Total RNA was isolated 
using the NucleoSpin RNA II Kit according to the manufacturers instructions. 
3.2.4.2. Reverse Transcription (cDNA synthesis)
8µl of total RNA eluate were mixed with 2 µl 0.1 µg/ml Oligo(dT) 12-18 Primer and heated 
to 65°C for 10 Minutes. After cooling to 4°C, a mastermix consisting of 2µl 10 mM dNTP-
Mix, 2µl 0.1 M DTT, 1µl 0.5 µg/ml RNaseOut, 1µl Superscript II Reverse Transcriptase 
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and 4 µl 5x first strand buffer [250 mM Tris-HCl (pH 8.3), 375 mM KCl, 15 mM MgCl2] 
were added. The mixture was incubated at 37°C for 90 minutes to synthesize cDNA 
and subsequently heated to 95°C for 2 minutes to inactivate the enzymes. The finished 
product was then diluted with 30 µl Nuclease-free water to a final volume of 50 µl.
3.2.4.3. Quantitative Real Time Polymerase Chain Reaction (RTq-PCR)
To determine gene expression in PCLS cDNA was amplified by RTq-PCR using the 
LightCycler 480 system by Roche based on TaqMan PCR technology. 1 µl cDNA was 
mixed with 9 µl mastermix consisting of 5 µl LightCycler 480 SYBR Green I Master, 3 µl 
PCR grade H2O and 0.5 µl forward and reverse primer, respectively.
Amplification was measured by addition of SybrGreen to the mastermix. SybrGreen 
intercalates into double-strand DNA and therefore reflects the amplification rate. 
Beta-2-microglobulin was used as housekeeping gene to normalize sample-to-
sample differences of the target DNA-Sequence. Relative DNA concentrations of the 
samples were calculated by an internal standard curve. The LightCycler 480 Relative 
Quantification Software analyses amongst other things the sample’s crossing point, 
the efficiency of the reaction and the number of cycles completed to define the 
final ratio as a function of PCR efficiency and determined crossing points. To control 
the specificity of the amplification, the melting temperature of every sample was 
determined. An individual, sharp peak indicates the desired product. 
In the absence of absolute copy numbers and accordingly concentrations of the target 
DNA sequence gene expression is given as a fold increase.
3.2.4.4. Primer
Oligonucleotide sequences were purchased lyophilised from MWG and dissolved to a 
stock solution of 100 nM/ml. Primer were diluted to a working solution of 0.625 nM/ml.
Gene Full name Primer sequences (5`-3`)
Areg amphiregulin FP ACCTGCCATTGTCATCAG
RP CGGCGGAGACAAAGACAA
B2M beta-2-microglobulin FP CCGTGATCTTTCTGGTGCTTGTCT
RP ATCGGTCTCGGTGGGTGTGAAT
Ptgs2 prostaglandin-endoperoxide synthase 2 (Cox-2) FP GGGTTGCTGGGGGAAGGAAT
RP ACCAGCAGGGCGGGATACAG
Il6 interleukin 6 FP CCAGCCAGTTGCCTTCTTG
RP AGTGCATCATCGCTGTTCATAC
Cxcl10 chemokine (C-X-C motif ) ligand 10 (IP10) FP GAACCCAAGTGCTGCTGT
RP GTCTCAGCGTCTGTTCATGG
Cxcl2 chemokine (C-X-C motif ) ligand 2 (MIP-2) FP AATGCCTGACGACCCTACCA
RP GTTAGCCTTGCCTTTGTTCAG
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Figure 3.2:  Incubation protocol with presence (+) and absence (-) of inhibitors after the 
slicing process.
3.2.5. Pharmacological intervention studies
3.2.5.1. Inhibitor protocol
Inhibitors were added to the slicing and incubation medium as indicated in Fig. 3.2.
3.2.5.2. Inhibitors of transcription and translation
To inhibit amphiregulin RNA induction the transcription and translation were blocked 
with different inhibitors (Table 3.1). Those were present during the slicing process and 
the first 4h of incubation. Afterwards the inhibitor was removed from the incubation 
medium. 
Table 3.1:   Inhibitors of transcription and translation
Inhibitor Function Solved in Concentration
Actinomycin D Forms a stable complex with the 
DNA, inhibits movement of the RNA 
polymerase 
Methanol 1 µg/ml
Cycloheximide inhibits translation Ethanol 20 µg/ml
5,6-Dichlorobenzimidazole 
riboside (DRB)
inhibitor of RNA synthesis DMSO 50 µM
Apicidin inhibitor of histone deacetylase Ethanol 2 µg/ml
3.2.5.3. Inhibitors and mediators of signal transduction pathways
To investigate the signal transduction pathways by which amphiregulin expression is 
mediated, different inhibitors were used (Table 3.2). PCLS were sliced and incubated 
for the first 4h in presence of the inhibitors. With the last medium change inhibitors 
were removed.
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Table 3.2:   Inhibitors of signal transduction pathways
Inhibitor Function Solved in Concentration
Imipramine inhibitor of acid 
sphingomyelinase
Milli Q H2O 10 µM
Y27632 Selective Rho-Kinase 
inhibitor
Milli Q H2O 10 µM
PP2 Selective Src-Tyrosine-
Kinase inhibitor
DMSO 10 µM
Sphingosine-1-phosphate Cellular metabolite, 
derived from ceramide
Methanol 1,32 µM
Genistein Specific inhibitor of 
tyrosine-specific protein 
kinases
DMSO 100 µM
Cytochalasin D Fungal toxin, inhibits 
actin polymerization
Ethanol 1 µM
ML-7 Selective inhibitor of 
MLCK
Ethanol 30 µM
Ruthenium Red Inhibits TRPV1, 4 and 
TRPA1, Ryanodine 
Receptor
Milli Q H2O 20 µM
Lanthanum Chloride Blocks divalent cation 
channels (e.g. Ca2+)
Milli Q H2O 100 µM
Dexamethasone Glucocorticoid anti-
inflammatory agent
H2O 1 µM
3.2.5.4. Storage of PCLS at 4°C and 37°C
Groups of PCLS were stored at 4°C or 37°C as indicated in Figure 3.3. Samples were 
harvested 4h, 8h, 24h and 48h after the slicing process.
Figure 3.3:  Incubation protocol of PCLS at different temperatures. 
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3.2.6. Pressure operated strain applying bioreactor
The bioreactor used for mechanostimulation consists of two sealed rigid chambers 
which are separated by a pliant carrier-membrane on which the test sample is fixed. 
After various futile attempts to fix the lung slices to the carrier membrane by gluing 
or letting them adhere to various membrane materials, we decided to fix the PCLS 
by clamping. The recently described bioreactor (232) was used with the following 
modifications. Two macrolon discs with an outer diameter of 30 mm and an aperture 
of 10 mm were placed between the upper and lower chamber of the bioreactor. By 
notches in an interval of 1.5 mm around the cut-out, leaving a space of approximately 
150 µm between the discs, a PCLS was fixed on a flexible supporting membrane in the 
bioreactor. The membrane and the PCLS were both clamped between the macrolon 
discs. The PCLS were stretched by applying pressure to the lower chamber of the 
bioreactor.
3.2.6.1. Membranes
Membranes were produced by the Group of Prof. Guttmann in Freiburg as described 
in detail previously (9). Briefly: polydimethylsiloxane (PDMS) is an organic-based 
dual-component polymer composed of base resin and curing agent. By a spin-
coating process inside a centrifuge, PDMS membranes were built by polymerisation 
of a two-component elastomer. During the spin-coating process, the material 
disperses, resulting in a plane film which is joined to a steel or macrolon ring. After 
the spin-coating process, the membranes were polymerised for 4h at 60°C resulting 
in an easy-to-handle membrane fixed in the carrier ring. The PDMS membranes had 
a thickness of approximately 30 µm with homogemous profiles as verified by optical 
coherence tomography. The elasticity of the membranes did not change during 24h of 
mechanostimulation.
3.2.6.2. Pressure application
PCLS were clamped into the bioreactor and pressure in the lower chamber of the 
bioreactor was measured with a custom built pressure transducer. Static pressure 
was applied using a syringe in order to determine the membrane excursions (needed 
for the strain calculations). The excursion of the lung slices was observed under a 
microscope and the excursion in Z-direction (height of the dome) was determined 
indirectly by means of a micrometer screw (see below). Cyclic pressure was applied 
using a constant pressure flow of 35 mbar to the lower chamber. A magnetic valve 
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was opened and closed in a 2 second rhythm to guarantee a periodic distension of the 
membrane. 
3.2.6.3. Displacement readings
Displacement of the membrane and the PCLS by pressure application was measured 
via stereomicroscopy equipped with a micrometer screw. Difference in altitude of the 
membrane corresponds exactly with the difference in height of the microscope while 
focusing the same plane. Displacement in mm can be measured.
Figure 3.4:  Influence of material parameters on the 
appearance of the stress-stretch curve. Exemplarily, a 
uniaxial tension test assuming perfect incompressibility of 
the tissue is investigated here. Plots show the relationship 
between the principal stretch λ and the Cauchy stress 
σ in load direction. In each subfigure, one constitutive 
parameter is varied arbitrarily, whereas the other two are 
kept constant. A: Variation of parameter c (dotted line: c 
= 0.1 kPa, solid line: c = 1 kPa, dashed line: c = 3 kPa). B: 
Variation of parameter k1 (dotted line: k1 =  30 kPa, solid 
line: k1 =  76.5 kPa, dashed line: k1 =  130 kPa). C: Variation of 
parameter k2 (dotted line k2 =  13.5 kPa, solid line k2 =  200 
kPa, dashed line k2 =  500 kPa).
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3.2.7. Mechanical model
Calculation of the strain was performed by Lena Wiechert (Group of Prof. Wall, 
München). The PDMS membrane and the tissue slice exhibit qualitatively comparable 
non-linear material characteristics – although individual quantitative tangential 
stiffnesses are very different – and can both be treated as isotropic, homogeneous 
continua. In the following, we assume an ideal clamping of the membrane-tissue 
construct in the bioreactor. Hence, membrane and tissue do not move relatively 
to each other for the pressure loadings considered here irrespective of their 
corresponding surface properties. Thus, slipping is supposed to be unlikely even if the 
surfaces were perfectly smooth. Experimental investigations in (9) also supported this 
assumption. Consequently, the resulting strain distribution is continuous across the 
membrane-tissue boundary. Since we are interested in the strains only – and not in the 
corresponding discontinuous stresses –, we modelled both components as one single 
homogeneous construct. 
In order to simulate the deformation of the construct in the bioreactor, an appropriate 
non-linear material model had to be chosen. In this connection, we postulated a 
decoupled strain-energy density function Ψ in terms of the invariants I1 and I3 of the 
right Cauchy-Green deformation tensor 
FFC T ⋅=
 
(with F  denoting the local deformation gradient). 
For the isochoric part, the following polyconvex function Ψiso (85; 293) was chosen
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with δ = 1 if I1 > 3 and δ = 0  otherwise. The involved material parameters characterize 
the form of the resulting stress-strain curve of the tissue as illustrated in Fig. 3.4. The 
shear modulus-like parameter c refers to the initial slope of the curve, whereas k1 ≥ 0 
and k2 > 0 affect the local slope as well as the curvature of the nonlinear posterior part.
The chosen volumetric function governing the transversal response of the membrane-
tissue construct 
Ψvol = κ β
-2 (β ln J - J-β - 1)
follows (189) with β = 9 being an empirical coefficient, )det(FJ =  and κ denoting a 
bulk modulus-like parameter. 
The material parameters were determined such that the simulated dome displacement 
matched the experimentally derived one as well as possible (Fig. 4.26.), yielding c = 
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10 kPa, κ = 8.3 kPa, k1 = 30 kPa and k2  = 8.5 kPa. It should be emphasized that these 
parameters are needed for simulating the construct’s behaviour only, so we do not 
intend to make any statement on the mechanical properties of the tissue slice alone 
here.
Nonlinear finite element (FE) simulations of the deformation in the bioreactor were 
performed with our in-house multi-purpose FE code BACI. By using the experimentally 
determined dome displacements as input to the model, further information on the 
local strain state of the tissue – which cannot be measured directly – should be 
provided. For this purpose, the membrane-tissue construct was discretized with 13300 
linear hexahedral elements and fixed at the circumferential surface. 
In order to specify the strain state of the membrane, the spatial stretch tensor
 1−⋅= RFv  
(with 1−R  being the inverse of the local rotation tensor) was calculated in every finite 
element node. After the solution of the associated eigenvalue problem, the principal 
spatial stretches λα  and corresponding directions
 αn
  (with [ ]3,2,1∈α ) were determined.
3.2.8. Videomicroscopy of alveoli
Pictures of the Alveoli were taken at specific pressure points with a Visicam camera. 
Area and perimeter were evaluated by area and line measurement in the Optimas 6.5 
software.
3.2.9. Treatment with collagenase
PCLS were incubated with 1 mg/ml collagenase H for 20 minutes at 37°C. After the 
incubation collagenase was removed by washing the PCLS with incubation medium.
3.2.10. Statistics
Data were analysed by either one factorial or multifactorial analysis in JMP 7. 
Heteroscedicity was correted by Box-Cox transformation prior to anylysis. Data were 
compared by the Tukey Hsd test (all versus all), Dunetts test (all versus control) or 
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Students t-test. Concentration-response curves, displacement curves and maximum 
contraction data were analysed in GraphPad Prism 5. 
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4. Results
4.1. Part I: Effect of mediators to Sheep PCLS
Sheep have been used as an asthma model, because they feature many 
pathophysiological characteristics of human asthma (3). However, sheep PCLS have 
yet not been established. In this study, production and responsiveness of sheep PCLS 
were studied. To investigate the responsiveness of mediators to sheep lung, adult 
sheep PCLS were compared to PCLS from premature baby sheep born by caesarian. 
4.1.1. Viability of sheep PCLS
The viability of adult and premature sheep PCLS was evaluated by measurement of 
mitochondrial function via MTT test. In contrast to detergent-treated PCLS (data not 
shown) both adult and premature sheep PCLS showed MTT formation for at least 
72h in culture, indicating viability of sheep PCLS for at least 3 days. Overall the MTT 
formation in premature sheep PCLS was higher compared to adult sheep PCLS. This 
difference was significant at 24h and 72h (Fig. 4.1).
Figure 4.1:  MTT formation in sheep 
PCLS. PCLS from adult (black columns) 
or premature sheep (dark grey 
columns) were cultured for 72h in 
incubation medium at 37°C and 5 % 
CO2. Data are given as mean ± SD, n = 
3 PCLS at minimum. Data was Box-Cox 
transformed and analysed by the Tukey 
HSD test.
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4.1.2. Airway responses of sheep PCLS
The bronchoconstriction to mediators relevant in asthma was compared in adult and 
premature sheep PCLS. Cumulative concentration-response curves were performed 
for methacholine, serotonin and endothelin-1. Furthermore, the airway reactivity to 
histamine, leukotriene D4 and U46619 was investigated. Both adult and premature 
sheep responded to methacholine, a stable acetylcholine derivative, with EC50 values of 
70 and 187 nM, respectively (Fig. 4.2 A). The biogenic amines serotonin and histamine 
were also tested in sheep PCLS. Serotonin contracted the airways with an EC50 value 
of 122 nM in adult sheep and an EC50 value of 377 nM in premature sheep (Fig. 4.2 B). 
Surprinsingly, both adult and premature sheep did not respond to histamine (Fig. 4.2 
C). No difference was observed in the concentration-response curves for endothelin-1, 
which constricted the airways with an EC50 value of 16 nM in adult and premature 
sheep PCLS (Fig. 4.2 D). As representatives for eicosanoids the stable TP-receptor 
antagonist U46619 and leukotriene D4 were applied (Fig. 4.2 E, F). Leukotriene D4 led to 
a bronchoconstriction in both adult and premature sheep airways. While the reaction 
of adult sheep was rather weak with a maximum contraction of 24.7 ± 20.4 % at 
concentrations of 100 nM, the premature sheep aiways contracted up to 77.6 ± 22.8 %. 
In contrast to premature sheep, which did not response to U46619, adult sheep airways 
contracted with a maximum of 33.5 ± 34.4 % at concentrations of 10 µM.
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4.1.3. Mediator-induced vasoconstriction in sheep PCLS
Vessels in PCLS can be observed by videomicroscopy in the same manner as airways. 
While bronchial arteries are too small to be examined, the pulmonary vessels are 
observable. Pulmonary arteries and veins can be distinguished by their relative 
location to the airway and the amount of smooth muscle arount the vessel. Whereas 
the pulmonary artery is located very close to the airway and is characterised by a lot 
of smooth muscle, the vein is located farther with lower amounts of smooth muscle. 
Because of the relatively close location of the pulmonary arteries to the airways, 
Figure 4.2:  Bronchoconstriction in response to different mediators in PCLS from adult (black line) 
and premature (grey line) sheep. Concentration-response curves are shown for methacholine (A), 
serotonin (B), histamine (C), and endothelin-1 (D). Airway response over time is shown for leukotriene 
D4 (E) and U46619 (F). Data are given as mean ± SEM, n = 8-14. 
A B
C D
E F
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pulmonary arteries were investigated if they were present in PCLS. Vasoconstriction 
of pulmonary arteries was investigated and compared in adult and premature sheep 
PCLS. Leukotriene D4, U46619 and endothelin-1 are also known to constrict vessels. 
Figure 4.3 shows the vasoconstriction of vessels to leukotriene D4, U46619 and 
endothelin-1. No difference was observed between adult and baby sheep in response 
to endothelin-1, pulmonary arteries were constricted by an EC50 value of 19 nM. Adult 
sheep did not react to leukotriene D4, however premature sheep at least reacted with 
a maximum contraction of 13.7 ± 18.7 % at concentrations of 100 nM. Both adult and 
premature sheep showed vasoconstriction to U46619 in a concentration dependent 
manner with maximum contractions of 29.8 ± 35.7 and 39.4 ± 30.9 % at concentrations 
of 10 µM, respectively. As expected, no vasoconstriction was observed in PCLS treated 
with methacholine, histamine or serotonin (data not shown).
Figure 4.3:  Vasoconstriction in adult (black 
line) and premature (grey line) sheep PCLS. 
Concentration-response curve of endothelin-1 (A) 
and constriction over a time period by leukotriene 
D4 (B) and U46619 (C). Data are given as mean ± 
SEM, n = 8. 
A B
C
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4.2. Part II: Effect of allergens to mouse PCLS
4.2.1. Effect of TMA and DNCB on lung function
The incidence of allergies is increasing and especially the lung and the skin play a 
critical role in allergen sensitisation. EU-projects like the Sens-it-iv project focus on 
the development of alternative in vitro models to animal testing, according to the 
3R-concept created by Russell and Birch (replace, reduce and refine (226)). The study 
was designed to examine wether airway responses in PCLS are a suitable alternative 
to in vivo studies, especially with a view to the 3R concept. The aim was to characterise 
lung function after dermal exposure and pulmonary challenge of mice with the LMW 
chemicals TMA and DNCB, which are well characterised chemical allergens. TMA is a 
known respiratory allergen, while DNCB works as a contact allergen. Therefore two 
different aspects of asthma were investigated. Furthermore the aim was to examine 
wether PCLS are a predictible in vitro model for in vivo experiments.
Irritant effects of both allergens were excluded beforehand; incubation with 1.2 µg/ml 
TMA and 0.3 µg/ml DNCB did not effect the viability of PCLS (data not shown). 
4.2.1.1. Induction of the EAR by TMA and DNCB
After dermal sensitisation with an allergen the EAR leads to a severe bronchoconstriction 
and inflammatory response after exposure to the corresponding allergen. To examine 
wether TMA and DNCB are able to induce EAR after active sensitisation, mice were 
provoked with TMA or DNCB, respectively. Invasive measurements to aquire lung 
function parameters are an established model. EAR of sensitised animals were studied 
after challenge with TMA or DNCB and compared to bronchoconstriction in PCLS of 
sensitised animals. No significant effect of TMA or DNCB on pulmonary resistance was 
observed (Fig. 4.4 A). Similarly airways of PCLS from sensitised and control animals did 
not contract after exposure to 1.2 µg/ml TMA and 1 µg/ml DNCB (Fig. 4.4 B). 
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4.2.1.2. AHR in sensitised PCLS
24h after allergen challenge the unspecific AHR was measured in vivo (Fig. 4.5 A). Only 
TMA-sensitised mice showed a reduction of the ED50 in response to methacholine 
(0.21 µg vs. 0.06 µg). Ex vivo the response towards methacholine was investigated in 
the PCLS that were challenged with the allergen 16h before (Fig 4.5 B). While DNCB 
sensitisation had no effect, TMA significantly decreased the EC50 for methacholine-
induced bronchoconstriction, indicating AHR. The corresponding EC50 values were 
0.41 µM and 0.24 µM methacholine, respectively.
Figure 4.4:  Comparison of the EAR in vivo and ex vivo. TMA- or DNCB-sensitised mice (A) or PCLS 
from sensitised mice (B) were challenged with TMA or DNCB. Sham sensitised animals with acetone 
or DMSO acted as a control. Bronchoconstriction in vivo is given as the percentage increase in 
pulmonary resistance and compared to the percentage in maximum airway contraction. In vivo 
experiments were accomplished by Maja Henjakovic (Hannover). Data are given as mean ± SEM, 
n = 6 to 12. Data were compared by the two-sided, unpaired t-test.
Figure 4.5:  AHR in vivo (A) and ex vivo (B). ED50 and EC50 of methacholine were determined by 
application of different doses/concentrations. The in vivo experiments were performed by Maja 
Henjakovic (Hannover). Data are given in mean ± SEM, n = 5 or 6 (allergen sensitisation) or 12 (sham 
sensitisation). Data were compared by the two-sided, unpaired t-test.
A B
A B
48
4. Results
4.3. Part III: Gene induction in PCLS
Amphiregulin has been identified as a gene that is upregulated specifically by 
mechanical stretch, while at the same time being unresponsive to inflammatory stimuli, 
such as LPS. Experiments in the isolated and perfused mouse lung model showed an 
induction of amphiregulin, specifically by overventilation and not influenced by LPS 
administration (65). The attempt to detect amphiregulin upregulation in stretched 
PCLS was complicated because of a strong upregulation of amphiregulin by the 
preparation procedure (Figure 4.6). The upregulation was significantly different in 
unfilled and agarose filled lung tissue.
Amphiregulin RNA expression was followed over time after the slicing process. A 
maximum induction was found 4h after the slicing process, which decreased after 24h. 
Nevertheless a significant upregulation persisted until 48h in culture (Fig. 4.7).
Figure 4.6:  Amphiregulin RNA 
expression in untreated lung tissue 
(Unfilled), agarose filled lung tissue 
(directly after preparation), and PCLS 
(after 24h in culture). Data are given 
as mean ± SD, n = 3. Data were Box-
Cox transformed and analysed by the 
Tukey Hsd test. * shows significant 
differences to unfilled tissue, + shows 
significant differences to agarose filled 
tissue.
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4.3.1. Gene induction 24h after the slicing process
To further examine gene expression in response to the slicing procedure, a gene array 
was performed comparing lung tissue to PCLS. 24h after the slicing process a variety 
of genes were upregulated, headed by immune response genes (Table 4.1). Besides 
classical inflammatory genes like Il-6 and Cxcl2 (MIP-2), also Lif, Csf3, Ccl7, Ccl2, Ptgs2 
(Cox-2), Mmp3 and Cxcl10 were upregulated in PCLS. Interestingly, also Serpine1 was 
induced by the slicing process, which is known to play a role in tissue regeneration 
and wound healing. The amphiregulin gene was less upregulated in comparison to the 
genes mentioned above (Table 4.1).
Figure 4.7:  Amphiregulin RNA 
expression in untreated lung 
tissue (Control) in comparison with 
expression in PCLS directly (0h), 4h, 
24h and 48h after the slicing process. 
Data are given as mean ± SD, n = 3. 
Data was Box-Cox transformed and 
analysed by the Tukey Hsd test. * shows 
significant differences to Control; § 
shows significant differences of the 4h 
group to all other groups. n.s. = non 
significant.
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Gene symbol Protein Fold increase 
(log 2)
Function
Il6 Interleukin-6 3.09 Immune response, response to 
mechanical stimulus, acute-phase 
response 
Lif Leukemia inhibitory factor 2.01 Immune response, cell surface receptor 
linked signal transduction, positive 
regulation of cell proliferation 
Csf3 Colony stimulating factor 
3 (granulocyte) 
1.96 Immune response 
Cxcl2 Chemokine ligand 2 (MIP-
2)
1.92 Chemotaxis, inflammatory response, 
immune response 
Ccl7 Chemokine (C-C motif ) 
ligand 7 
1.89 Transport, chemotaxis, inflammatory 
response 
Mmp3 Matrix metallo- peptidase 
3 
1.88 Peptidoglycan metabolic process, 
proteolysis, collagen catabolic process 
Ptgs2 Prostaglandin-
endoperoxide synthase 2 
(Cox-2)
1.84 Regulation of progression through 
cell cycle, prostaglandin biosynthetic 
process, cyclooxygenase pathway
Serpine1 Serine peptidase inhibitor 1.82 Response to reactive oxygen species, 
blood coagulation, wound healing, 
tissue regeneration 
Ccl2 Chemokine ligand 2 1.77 Positive regulation of endothelial cell 
proliferation, chemotaxis, inflammatory 
response 
Cxcl10 Chemokine ligand 10 1.75 Chemotaxis, inflammatory response, 
electron transport 
Areg Amphiregulin 1.33 Epidermal growth factor receptor 
signaling pathway
4.3.2. RNA expression 
4.3.2.1. RTq-PCR
To validate the gene induction, RNA expression of selected genes was determined 24h 
after the slicing process by RTq-PCR (Fig. 4.8). IL-6 was upregulated to a great extend 
followed by MIP-2, Cox-2, IP-10 and amphiregulin. Larger than thousand fold increases 
may be explained by the relatively low levels of the corresponding RNA in untreated 
lung tissue.
Table 4.1:   Gene induction by the slicing process as fold increase of the log 2 values 
compared to untreated lung tissue. Amphiregulin was not among the 10 top candidate 
genes, but still upregulated to a great extent.
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4.3.2.2. RNA expression of immune response genes
The induction of IL-6, MIP-2, Cox-2 and IP-10 was investigated by RTq-PCR (Fig. 4.9). 
RNA expression was determined 4h, 24h and 48h after the slicing process. Untreated 
lung tissue (neither agarose filled nor sliced; the left lower lung lobe was separated 
by a clamp before the agarose filling) served as control. RNA expression was also 
determined directly after the the slicing process (0h) before the PCLS were taken into 
culture at 37°C and 5 % CO2.
Directly after the slicing process both IL-6 and MIP-2 were significantly induced. 
Maximum RNA expression was observed after 24h for IL-6 and MIP-2. After 48h the 
expression was reduced, but was still significantly upregulated in comparison with 
untreated lung tissue. Cox-2 upregulation also started directly after the slicing process 
Figure 4.8:  RNA induction 24h after the slicing process. Gene induction of IL-6, MIP-2, Cox-2, IP-10 
and amphiregulin was determined in a gene array experiment (small insert) and verified by RTq-
PCR. RNA data are given as mean ± SD, n = 3.
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and reached its maximum after 4h. This level of mRNA expression persisted until 48h 
after the slicing process.
IP-10 was upregulated to a maximal extent 4h after the slicing process. After 24h, the 
mRNA level was slightly, but not significantly, reduced. 48h after the slicing process 
there was a significant reduction in IP-10 levels compared to the 4h and 24h level. 
Nevertheless, also IP-10 was still significantly induced after 48h compared to the 
control. Like amphiregulin, IP-10 was not significantly induced directly after the slicing 
process.
Figure 4.9:  RNA expression after preparation of PCLS. Fold increase of IL-6 (A), MIP-2 (B), Cox-2 (C) 
and IP-10 (D) mRNA is shown 0h, 4h, 24h and 48h after the slicing process, compared to untreated 
lung tissue (Control). A: IL-6 mRNA induction after the slicing process; * shows significant differences 
to Control; + shows significant differences to the 0h group and § shows significant differences of 
the 4h group to the 24h and 48h group. B: MIP-2 mRNA induction after the slicing process; * shows 
significant differences to Control; $ shows a significant difference between the 0h group and the 
24h group; + shows a significant difference between the 24h group and the 48h group. C: Cox-2 
mRNA induction after the slicing process * shows significant differences to Control. D: IP-10 mRNA 
induction after the slicing process; * shows significant differences to Control; + shows a significant 
difference between the 24h group and the 48h group. n.s. = non significant. Data are given as mean 
± SD (n = 3). Data was Box-Cox transformed and analysed by the Tukey Hsd test, p-values < 0.05 were 
considered significantly different. 
A B
C D
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4.3.2.3. RNA induction by LPS application
To investigate wether the RNA induction by the slicing process can be induced further, 
PCLS were treated with LPS 24h after the slicing process, because LPS is known to 
induce genes of the inflammatory response. Treatment of PCLS with LPS for 1h further 
induced IL-6, MIP-2, Cox-2 and IP-10 expression, indicating that the slicing process 
does not maximally increase the response of these genes (Fig. 4.10). In contrast to MIP-
2, Cox-2 and IP-10 RNA expression the induction of IL-6 by LPS was not significant. As 
Figure 4.10:  RNA induction 24h after the slicing 
process by LPS. PCLS were treated with LPS for 
1h and expression of amphiregulin (A), IL-6 (B), 
MIP-2 (C), Cox-2 (D) and IP-10 (E) was measured in 
comparison with untreated lung tissue (control) 
and untreated PCLS (24h). * shows significant 
differences to Control; + shows a significant 
difference between untreated PCLS and LPS-
treated PCLS; n.s. = non significant. Data are 
given as mean ± SD, n = 3. Data was Box-Cox 
transformed and analysed by the Tukey Hsd test, 
p-values < 0.05 were considered significantly 
different.
A B
C D
E
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expected from IPL mouse data, LPS did not induce amphiregulin expression confirming 
the fact that amphiregulin is not upregulated by LPS. In fact there was a tendency of 
reduction in amphiregulin RNA expression after LPS treatment.
4.3.2.4. Incubation of PCLS at 4°C and 37°C
Amphiregulin, IL-6, MIP-2, Cox-2 and IP-10 were all upregulated by the slicing process. 
However, the maximum induction of each gene is reached after 4h to 24h incubation 
at cell culture conditions. To investigate the different factors which may contribute 
to the induction of the genes after the slicing process, we examined the effect of 
temperature. PCLS were kept at 4°C instead of incubating them at 37°C. Media changes 
were performed at 4°C. Comparison with PCLS incubated at 37°C showed no gene 
induction for IL-6, MIP-2, Cox-2 or IP-10, independent of the time period PCLS were 
kept at 4°C (4h or 24h, Fig. 4.11).
Figure 4.11:  RNA expression 4h and 24h after the slicing process. PCLS were either incubated at 4°C 
or 37°C and induction of IL-6 (A), Mip-2 (B), Cox-2 (C) and IP-10 (D) was measured. Data are given as 
mean ± SD, n = 3. Data was Box-Cox transformed and analysed by the Tukey Hsd test, p-values < 0.05 
were considered significantly different.
A B
C D
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Amphiregulin induction was also measured after incubation at 4°C (Fig. 4.12). No 
induction was observed in PCLS incubated at 4°C after 4h and 24h. To investigate 
whether the maximum induction after 4h at 37°C was reduced by the 4°C incubation, 
PCLS were incubated at 4°C for 20h and 44h before incubation for 4h at 37°C. Incubating 
the PCLS for 20h at 4°C did not prevent the amphiregulin induction after 4h at 37°C, 
which was comparable to the induction observed in PCLS directly incubated for 4h at 
37°C after the slicing process. Only PCLS incubated for 44h at 4°C showed a significant 
reduction in amphiregulin induction after incubation at 37°C for 4h (Fig. 4.12 B). 
Figure 4.12:  RNA expression of amphiregulin after 4h at 37°C. Panel A shows a comparison of PCLS 
incubated at 37°C and 4°C. Data are given as mean ± SD, n = 3. B: Amphiregulin induction after 4h 
at 37°C. PCLS were incubated for 0h (black column), 20h (grey column) and 44h (white column) at 
4°C before they were incubated at 37°C for 4h. * shows significant differences to 0h incubated PCLS; 
+ shows a significant difference between 0h and 44h incubated PCLS.  Data are given as mean ± 
SD, n = 3. Data was Box-Cox transformed and analysed by the Tukey Hsd test, p-values < 0.05 were 
considered significantly different.
A B
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4.3.2.5. Viability of PCLS incubated at 4°C
PCLS were taken into culture at 37°C to mimic the physiological condition found in 
the body. To investigate whether the storage of the PCLS at 4°C had negative effects 
on the viability, MTT formation was measured after 24h and 48h. Incubation of PCLS 
at 4°C had no influence on the viability of PCLS compared to PCLS directly incubated 
at 37°C (Fig. 4.13).
4.3.2.6. Influence of agarose filling
Another parameter investigated was the agarose filling of the lung (Fig. 4.14). Although 
the agarose is washed out of the PCLS during the incubation at 37°C there is still a 
distending stimulus being filling the lung. Shortly after the slicing process no induction 
in the filled lung was measured. Incubation of a part of the filled lung in medium at 
37°C for 4h led to an induction of IL-6, MIP-2, Cox-2, IP-10 and amphiregulin. Compared 
to the induction by the slicing process the expansion stimulus seems to be less intense.
These data indicate that induction of genes is dependent on incubation at 37°C. The 
extension stimulus seems to be the first impulse leading to an upregulation of genes, 
while the slicing procedure may be a second cause of induction. Incubation of PCLS at 
4°C after the slicing process does not prevent amphiregulin induction at 37°C; it only 
reduces it to a certain level if the PCLS are incubated for 44h at 4°C.
Figure 4.13:  Viability of PCLS 
after incubation at 4°C and 37°C. 
Mitochondrial activity was measured 
24h after the slicing process in PCLS 
incubated at 37°C (black column), 4°C 
(white column) and in PCLS incubated 
for 20h at 4°C and 4h at 37°C (grey 
column). Measurement after 48h show 
PCLS incubated at 37°C (black column), 
incubated at 4°C (white column), 
incubated at 4°C for 20h and 28h at 
37°C (grey column with stripes) and 
PCLS incubated at 4°C for 44h and 4h 
at 37°C (checked grey column). Data 
are given as mean ± SD, n = 3. Data was 
Box-Cox transformed and analysed by 
the Tukey Hsd test.
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4.3.2.7. Inhibition of amphiregulin induction in PCLS
It was our aim to inhibit the amphiregulin induction by the slicing procedure, to 
differentiate a stretch specific induction by distension of the PCLS. To evaluate 
whether the gene induction during the preparation of the PCLS could be diminished 
by inhibition of the transcriptional level, different inhibitors of transcription and 
translation were used. Amphiregulin was the gene of special interest; because the 
final aim was to induce it by overexpansion of PCLS. Four different transcription 
inhibitors were added during the slicing process and for the next 4h. Actinomycin D, 
Figure 4.14:  Influence of agarose 
filling of the lung. Lung filled with 15 
ml agarose and incubated for 4h at 
37°C. Gene expression of IL-6, MIP-2, 
Cox-2, IP-10 and amphiregulin was 
measured. Data are given as mean ± SD, 
n = 3. Data was Box-Cox transformed 
and analysed by ANOVA and Dunetts 
test, p-values < 0.05 were considered 
significantly different.
Figure 4.15:  Amphiregulin RNA expression in PCLS treated with the transcription inhibitors DRB 
(A) or apicidin (B). Left panel shows control PCLS (black columns) compared with DRB treated PCLS 
(grey columns) 4h and 24h after the slicing process. Right panel shows control PCLS (black columns) 
compared with Apicidin treated PCLS (grey columns) 4h and 24h after the slicing process. PCLS were 
treated with 50 µM DRB or 2 µg/ml apicidin. Data are given as mean ± SD, n = 3. Data was Box-
Cox transformed and analysed by the Tukey Hsd test, p-values < 0.05 were considered significantly 
different (*); n.s. = non significant.
A B
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an inhibitor of the RNA polymerase and cycloheximide, a translational inhibitor were 
tested alone and in combination. Preliminary experiments showed that actinomycin 
D almost completely blocked the amphiregulin induction for at least 24h, but slicing 
or stretching did not induce amphiregulin (data not shown). Cycloheximide reduced 
the induction only partly and after 24h the amphiregulin induction was comparable 
to that in untreated PCLS. The simultaneous treatment with both inhibitors resulted 
in the same complete inhibition as observed for actinomycin D (data not shown). 
Furthermore, the RNA synthesis inhibitor 5,6-Dichlorobenzimidazole riboside (DRB) 
and apicidin, an inhibitor of the histone deacetylase were used (Fig. 4.15). Both 
inhibitors were able to reduce the amphiregulin induction significantly. After 24h it 
tended to be increased in DRB treated PCLS compared with untreated control PCLS. 
Thus, DRB is only effective for 4h and subsequently it may intensify the induction. 
Apicidin still blocked the amphiregulin induction significantly after 24h, but it was not 
possible to induce amphiregulin by 4h stretch (data not shown).
In general, transcriptional and translational inhibitors were able to reduce the 
amphiregulin induction. Unfortunately, their effectiveness was either too strong or not 
long lasting.
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4.3.3. Mechanisms of amphiregulin induction in PCLS
Because of the massive induction of amphiregulin in PCLS after the slicing process, 
different inhibitors were used to investigate the mechanism of amphiregulin induction. 
The highest upregulation could be observed 4h after the slicing process. Therefore 
inhibitors were added during the slicing process and for the next 4h of incubation. 
The aim was to reduce the maximum induction 4h after the slicing process to possibly 
diminish the overall induction of amphiregulin. Without inhibition the increase in 
amphiregulin after 24h is still too high to re-induce it by stretch or to differentiate 
stretch-induction from the basal level.
4.3.3.1. Influence of tyrosine kinases
The specific tyrosine kinase inhibitor genistein and the selective Src-tyrosine-kinase 
inhibitor PP2 were used to examine the influence of tyrosine kinases on amphiregulin 
induction (Fig. 4.16). Genistein inhibited amphiregulin induction at 4h after the slicing 
process. After 24h there was no difference between solvent and genistein-treated 
PCLS. PP2 significantly reduced amphiregulin induction after 4h compared to solvent-
treated PCLS. After 24h there was no more difference between solvent-treated and 
PP2-treated PCLS.
Figure 4.16:  Amphiregulin expression in PCLS 4h and 24h after the slicing process treated with 100 
µM of the tyrosine-kinase-inhibitor Genistein (A) and 10 µM of the Src-tyrosine-kinase inhibitor PP2 
(B). Solvent-treated PCLS are illustrated as black columns and inhibitor-treated PCLS as grey columns. 
Data are given as mean ± SD, n = 6 – 7 (Genistein) and 3 (PP2). Data was Box-Cox transformed and 
analysed by the Tukey Hsd test, p-values < 0.05 were considered significantly different (*); n.s. = non 
significant.
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These data indicate a role of tyrosine kinases in amphiregulin induction, possibly by 
Src-tyrosine kinases. After 4h a reduction of amphiregulin was observed, which was 
not seen 24h after the slicing process.
4.3.3.2. Influence of Sphingolipids
Sphingolipids, derived from the plasma membrane, are known to play an important 
role in the lungs (269). Acid sphingomyelinase generates ceramide, a constituent of 
ceramide-rich microdomains and a second messenger. Stress is well known to activate 
the acid sphingomyelinase, and therefore PCLS were treated with imipramine, an 
inhibitor of the acid sphingomyelinase pathway. Furthermore, PCLS were treated 
with sphingosine-1-phosphate that exerts protective effects in several insults (Fig 
4.17). Again treatment was maintained during and for 4h after the slicing process. 
No influence of the inhibition of the acid shingomyelinase was observed, neither 4h 
nor 24h after the slicing process. Treatment with sphingosine-1-phosphate increased 
the amphiregulin induction significantly 4h after the slicing process. There may be an 
activating effect on amphiregulin induction by sphingosine-1 phophate, which seems 
to be independent from acid sphingomyelinase.
4.3.3.3. Influence of calcium and ion-channels
Lanthanum chloride is used to block divalent cation channels, mainly calcium 
channels, and has been used as an unspecific inhibitor of stretch-activated ion 
channels (114; 227). Another selective calcium channel inhibitor is ruthenium red, 
Figure 4.17:  Amphiregulin RNA expression in PCLS treated with either 10 µM imipramine (A) or 
1.32 µM sphingosine-1-phosphate (B). RNA expression was measured 4h and 24h after the slicing 
process. Solvent-treated PCLS are illustrated as black columns and inhibitor-treated PCLS as grey 
columns. Data are given as mean ± SD, n = 3. Data was Box-Cox transformed and analysed by the 
Tukey Hsd test, p-values < 0.05 were considered significantly different (*); n.s. = non significant.
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especially blocking TRPV channels and the ryanodine receptor (96; 306). As another 
approach, calcium in the slicing and incubation medium was reduced to 10 % of the 
normal amount (4.18). The treatments were applied during the slicing process and 
4h thereafter. Reduced extracellular calcium slightly reduced amphiregulin induction 
after the slicing process, but this was not significant. 24h after the slicing process there 
was no difference in amphiregulin induction compared to control PCLS. No effect on 
amphiregulin induction was observed by treatment with lanthanum chloride (Fig. 4.19 
B). Ruthenium red increased amphiregulin induction significantly 24h after the slicing 
process (Fig. 4.19 A).
Figure 4.18:  Am p h i r e g u l i n 
induction in PCLS sliced and 
incubated in low calcium 
medium (grey columns, calcium 
reduced to 10 % of the normal 
amount) 4 and 24h after the 
slicing process. Control PCLS 
incubated in normal medium 
are illustrated as black columns. 
Data are given as mean ± SD, n = 
3. Data was Box-Cox transformed 
and analysed by the Tukey Hsd 
test, n.s. = non significant.
Figure 4.19:  Amphiregulin induction in PCLS sliced and incubated for 4h with either 20 µM 
ruthenium red (A) or 100 µM lanthanum chloride (B), shown as grey columns. Control PCLS incubated 
in normal medium are illustrated as black columns. Data are given as mean ± SD, n = 3. Data was Box-
Cox transformed and analysed by the Tukey Hsd test, p-values < 0.05 were considered significantly 
different (*); n.s. = non significant.
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In general reduced calcium does not appear to play a major role in amphiregulin 
induction, which does not seem to be mediated by store operated calcium channels, 
TRPV, or the ryanodine receptor.
4.3.3.4. Influence of the cytoskeleton
To investigate, whether the cytoskeleton plays a role in mediating the induction of 
amphiregulin, different inhibitors were used during the slicing process and 4h after it. 
Y27632 is an inhibitor of the rho-kinase, which is involved in the organisation of the 
actin cytoskeleton. Besides inhibiting the Rho-kinases, cytochalasin D, a fungal toxin, 
which inhibits actin polymerisation, was employed. In addition, myosin light chain 
phosphorylation was blocked by ML-7. No decrease in amphiregulin induction was 
found after treatment with Y27632 (Fig. 4.20). 
ML-7 and cytochalasin D both inhibited the maximum induction 4h after the slicing 
process (Fig. 4.21). In case of ML-7 this reduction was significant. Therefore an 
involvement of the myosin light chain kinase and the actin filaments is probable.
Figure 4.20:  PCLS were treated 
with 10 µM Y27632 (grey 
columns) and amphiregulin 
RNA expression was compared 
to control (black columns) PCLS 
after 4 and 24h. Data are given as 
mean ± SD, n = 3. Data was Box-
Cox transformed and analysed 
by the Tukey Hsd test, n.s. = non 
significant.
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4.3.4. Amphiregulin induction in response to chemical substances
Amphiregulin has been shown to be induced by physical injury such as stretch or 
slicing. To investigate whether it is also inducible by chemical stress like allergens or 
reactive oxygen species, PCLS were treated with TMA, DNCB or H2O2 for 4h. No further 
induction by the substances was observed 24h after the slicing process (4.22). This 
could be explained by the high basal induction as observed for stretch experiments.
Figure 4.21:  Amphiregulin RNA expression in PCLS treated with 30 µM ML-7 (A) and 1 µM 
cytochalasin D (B). Solvent-treated PCLS are illustrated as black columns and inhibitor-treated PCLS 
as grey columns. Data are given as mean ± SD, n = 6. Data was Box-Cox transformed and analysed by 
the Tukey Hsd test, p-values < 0.05 were considered significantly different (*); n.s. = non significant.
A B
Figure 4.22:  Amphiregulin induction 
in PCLS after treatment with 0.05 % 
DMSO (solvent), 1.2 µg/ml TMA, 1 µg/
ml DNCB and 10 µM H2O2. No significant 
difference was found in treated PCLS 
compared to untreated control PCLS. 
Data are given as mean ± SD, n = 3. 
Data was Box-Cox transformed and 
analysed by the Tukey Hsd test.
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4.4. Part IV: Distension of PCLS in a bioreactor
The bioreactor, as a pressure operated strain applicator, was first described in 2008 by 
Schumann et al. (232). A pressure-driven strain-applicator was developed, which uses 
spherical deflection of a carrier membrane to transmit tensile strain to a biological 
sample placed on top of it. At that time the experiments where done with test 
membranes serving as a physical model of biologic tissue. It was our aim to establish 
the distension of PCLS in the bioreactor. 
4.4.1. Membranes
Evaluating the performance of the bioreactor Schumann et al. used polyurethane and 
latex membranes of well defined and highly reproducible material characteristics (232). 
To measure strain applied to lung tissue the membrane preferably would have similar 
characteristics to the tissue, in particular with respect to the stiffness. Furthermore, 
it should be flexible to allow proper dynamic deformations, yet maintain its material 
characteristics (no plasticity). The first membrane we tested was a thin, highly 
flexible silicone membrane. The membrane was placed in a plastic membrane holder 
and fixated by a second plastic ring by clamping it. This fixation assembly became 
problematic because it was impossible to clamp such a thin membrane crease-free 
between the two plastic rings. A second problem became apparent after distension 
of the membrane, which revealed its plastic deformability. To overcome the problems, 
the membrane concept was changed to another fixation technique and different 
membrane material. Polyurethane membranes were crease-free glued on a metal 
ring, which was placed in the membrane holder. Polyurethane membranes are much 
Figure 4.23:  Different membranes tested in the 
bioreactor. (A) Polyurethane membrane glued 
on a metal ring, (B) PDMS membrane on a metal 
ring, (C) PDMS membrane on a macrolon ring, (D) 
Stained PDMS membrane on a macrolon ring.
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thicker and therefore stiffer, but the plastic deformation was reduced. To reduce the 
stiffness, a third membrane material was tested. Polydimethylsiloxane (PDMS) shows 
a minimal plastic deformation although it is very flexible. By a spin-coating process it 
can be cast directly on a metal or macrolon ring with a thickness of about 30 µm. The 
membranes were tested with isolated rat diaphragms (9). For the above mentioned 
reasons, PDMS membranes were considered as the most suitable membranes to 
distend PCLS. Different membrane types are shown in Fig. 4.23.
4.4.2. Fixation of the lung slice
Most cell stretch devices work with cells grown directly on flexible membranes. 
However, PCLS did not adhere on the membranes or substrates that we tried. Therefore 
we attempted to glue the PCLS on top of the membrane using a tissue adhesive. 
Unfortunately the PCLS only properly adhered by glueing the whole undersurface of 
the PCLS on the membrane, which stiffened the tissue in that area completely. Hence, 
tissue characterics were not maintained anymore and the stiff underside of the PCLS 
would have interfered with strain measurements. Therefore, the new approach was 
the mechanical fixation of a PCLS in the bioreactor. Two macrolon discs were designed 
to clamp the membrane and the PCLS concentrically, leaving an aperture for the 
distension of the slice (Fig. 4.24). The concentrically grooved surface clamped the PCLS 
for 2 mm at the fringe. A space of approximately 150 µm remained between the crests 
to compress and fixate the PCLS. The clamped and thus damaged tissue was removed 
after the distension and the PCLS was used for further analysis. 
Figure 4.24:  Schematic 
view of the clamping 
adapter device. The 
inner cogging was 
specifically designed 
to fixate very soft 
tissues, such as lung 
parenchyma. Panel A 
shows one macrolon 
disc from different 
points of view. In panel 
B the fixation clamp 
is shown, the circle in 
the upper picture is 
magnified below.
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4.4.3. Static distension of the PCLS
4.4.3.1. Displacement readings
For static distension, pressure was increased in steps by injecting air in the lower 
chamber of the bioreactor. At pressures higher than 52 mbar the PCLS became 
disrupted, hence 52 mbar were defined as the maximum pressure. Membranes were 
mounted in the bioreactor as detailed below and varying pressures were applied. 
Displacement was measured by microscopy-based distension measurement at the 
center of the slices (Fig. 4.25). At 52 mbar the maximum excursion of the tip was 
approximately 4.5 ± 0.7 mm. Next, lung slices were mounted in the bioreactor and 
stretched under static conditions by applying varying pressures to the lower chamber. 
If lung slices were mounted onto the PDMS membranes, the excursion at pressures 
above 30 mbar was reduced in comparison to membranes alone and the maximum 
distension was about 3.5 ± 0.5 mm. 
Figure 4.25:  Excursion of membranes 
without (black) and with PCLS 
mounted onto them (grey). Data are 
given as mean ± SD, n = 11. Curves 
were compared by using the best-fit 
value of the parameters BMAX and KD 
by F-test, resulting in different curves 
for each data set.
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4.4.3.2. Finite element model
To determine the strain distribution in the lung slices, the distension of the PCLS 
was modelled by finite elements. The numerical simulation was compared to the 
experimental data. The result is shown in Figure 4.26, illustrating the tip displacement 
of the membrane-tissue construct for varying pressures. At all pressures the numerical 
simulation and the experimental data were well compatible (Fig. 4.26 A). The numerically 
determined deformation states of the membrane tissue construct at pressures of 35 
and 52 mbar are depicted in Figure 4.26 B.
Principal stretches in the longitudinal, latitudinal and transversal direction were 
analysed in Figure 4.27. The stretch in the latitudinal direction was up to 33 % at 35 mbar 
and up to 38 % at 52 mbar, with maximum values at the dome. The longitudinal stretch 
Figure 4.26:  Distension of membrane-tissue construct. A: Tip displacement of the membrane-tissue 
construct under varying presures. The black line refers to experimentally measured deformation 
states, whereas the grey line represents numerical results obtained in a FE simulation. Curves were 
compared by F-test resulting in shared curves for each data set. B: Absolute vertical displacements 
d [mm] of membrane-tissue construct under a hydrostatic pressure load of 35 and 52 mbar.
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of the lung tissue accounted for 22 % - 36 % at 35 mbar and between 27 % - 44 % 
at 52 mbar, with maximum values occurring outside the dome region. At the dome, 
longitudinal stretches were around 33 % at 35 mbar and 38 % at 52 mbar, hence 
an isotropic stretch state developed as expected. In the transversal direction the 
membrane became thinner by 13 % - 26 % at 35 mbar and by 20 % - 35 % at 52 mbar.
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Figure 4.27:  Distribution of principal stretch directions and the corresponding principal stretches 
at 35 (left panel) and 52 mbar (right panel). A: transverse direction. B: latitudinal direction. C: 
longitudinal direction.
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4.4.3.3. Distension of alveoli
Lung slices stretched in the bioreactor were observed under a microscope (Fig. 4.28). 
Individual alveoli were marked and their perimeter and area recorded. The alveolar 
perimeter and area increased nearly linearly over the range of pressures and membrane 
excursions examined. The area of the alveoli increased up to 78 % ± 15.8. Based on the 
change in alveolar perimeter the mean stretch was 24.9 ± 4.1 % at 35 mbar and 35 
± 8.5 % at 52 mbar. Similar data were obtained by decreasing pressures in the same 
manner. No hysteresis was observed (Fig. 4.29).
Figure 4.28:  PCLS in the bioreactor under static stretch. A, B: The PCLS before stretching. Panel A 
shows an overview and Panel B a magnified portion of panel A. C, D: The same PCLS shown in panel 
B after application of 35 mbar (C) and 52 mbar (D). One single alveolus is marked. The horizontal bar 
corresponds to 2 mm in panel A and 0.1 mm in panels B-D.
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4.4.3.4. Influence of Collagenase H
For the stress-strain relationship static distension was applied by means of displacement 
adjustment. PCLS were mounted in the bioreactor with a starting pressure of 5 mbar, 
to avoid variations at the starting point. The tip distension was statically increased by 
0.5 mm steps up to 2 mm and the pressure in the lower chamber was determined. At 
2 mm the pressure was at 46.8 ± 6.2 mbar. To investigate the influence of the collagen 
fibers, PCLS were treated with Collagenase (Fig. 4.30). Subsequently, more than 90 % 
of the PCLS disintegrated at a displacement of 2 mm. However, in collagenase-treated 
PCLS, pressures were reduced to 36.08 ± 4.57 mbar at 2 mm tip displacement. These 
values were close to the characteristics of the membranes, which resulted in pressures 
of 31.25 ± 4.4 mbar at 2 mm displacement. Interestingly, at a tip displacement of 
1.5 mm and pressures of 28.9 ± 5.2 mbar, collagenase-treated PCLS were still intact 
(approximately 90 %). 
Figure 4.29:  Change in alveolar area plotted against increasing (black line) and decreasing (grey 
line) pressure (A) and tip distension (B). Perimeter change was also plotted against increasing (black 
line) and decreasing (grey line) pressure (C) and tip distension (D) . Data are given as mean ± SD; 
n = 5 (minimum 17 PCLS). 
A B
C D
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Analogue experiments were performed within the same PCLS. Distension of a PCLS 
once, followed by incubation with collagenase and subsequent distension, resulted in 
a tendentially decreased pressure at 2 mm displacement (45.3 ± 6.2 vs. 41 ± 1.4 mbar) 
after collagenase treatment. Still the rate of disintegrated, collagenase-treated PCLS 
at 2 mm tip displacement was very high (more than 70 %). Incubating the PCLS with 
medium instead of collagenase resulted in comparable curves within one PCLS (Fig. 
4.31).
Figure 4.30:  Influence of collagenase treatment to PCLS. A: Pressure curve in the lower chamber 
of the bioreactor after tip distension. Untreated PCLS are shown as a black curve and collagenase 
treated PCLS as a grey curve. Curves of untreated PCLS and collagenase treated PCLS were compared 
by using the best-fit value of the parameters BMAX and KD by F-test and were found to have a 
different slope. The dark grey dotted curve shows the membranes (mean only). Data are given as 
mean ± SD, n = 3. B: Survival of the same PCLS shown in panel A in percent after displacement. Again 
the curve of control PCLS is shown in black and the collagenase treated PCLS in grey. 
Figure 4.31:  D i sp l a cement 
of the PCLS in the bioreactor 
and resulting pressure curves. 
PCLS before (black line) 
and after (grey dotted line) 
collagenase treatment. The 
small inserted graph shows 
the survival before (black line) 
and after (grey dotted line) 
collagenase treatment. Data 
are given as mean ± SD, n = 3.
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4.4.4. Distension of PCLS under dynamic conditions
4.4.4.1. Viability of stretched PCLS
Longitudinal stretch between 10 % and 25 % is generally considered to be relevant for 
stretch-induced cell activation and ventilator-induced lung injury. According to the 
static measurements this degree of stretch is obtained by applying 35 mbar in our 
model system. Because cyclic stretch is more relevant and also appears to be more 
injurious than static stretch (268) we studied the viability of PCLS stretched for 4h 
up to 35 mbar at 0.25 Hz. Four hours of dynamic stretch did not alter MTT reduction 
compared with non-stretched controls, while there was a significant decrease in MTT 
reduction in detergent (triton X100)-treated PCLS (Fig. 4.32). 
To further illustrate viability, PCLS were stained for dead cells with propidium iodide and 
pictured by confocal microscopy (Fig. 4.33 A-C)). Comparing the non-stretched control 
PCLS to the 4h stretched PCLS, the amount of dead cells was not significantly different. 
The detergent treated PCLS in contrast showed a huge amount of dead cells. However, 
the amount of dead cells in control and stretched PCLS was relatively high, probably 
because pictures were taken relatively close to the slicing area. Therefore, the same 
experiment was repeated with live-dead staining and examined with multi-photon 
microscopy (Fig. 4.33 D-F) using calcein AM as a marker of living cells and ethidium 
homodimer as a marker of dead cells, to gain inside into deeper layers of tissue. The 
overall amount of dead cells was reduced and there was again a comparable amount 
Figure 4.32:  M i t o c h o n d r i a l 
activity determined by MTT-Test. 
MTT formation in non-stretched 
controls and 4h stretched 
PCLS is comparable while it 
was significantly decreased in 
detergent treated PCLS. Data are 
given as mean ± SD, n = 5. * shows 
a significant difference between 
the Control and TritonX-100 
group; + shows a significant 
difference between the 4h 
Stretch and TritonX-100 group. 
Data was Box-Cox transformed 
and analysed by the Tukey Hsd 
test.
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of dead cells in the non-stretched control and the 4h stretched PCLS. Many nuclei were 
stained in the detergent treated PCLS. 
Figure 4.33:  Viability of 4h stretched PCLS. A-C: PCLS were stained for dead cells (nuclei) with 
propidium iodide (red) and overlayed with autofluorecence (green). Non-stretched control PCLS (A) 
were compared to 4h stretched PCLS (B) and detergent (Triton-X 100) treated PCLS (C). Detergent 
treated PCLS serve as a positive control with all nuclei stained. D-E: 2 photon microscopic images 
of a non-stretched control PCLS (D), a 4h stretched PCLS (E) and a detergent treated PCLS (F). PCLS 
were treated with LIVE/DEAD staining (Calcein AM (green, cytoplasm) for living cells and ethidium 
homodimer (red, nuclei) for dead cells).
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4.4.4.2. Amphiregulin RNA expression in stretched PCLS
Amphiregulin was shown to be upregulated specifically by overdistension of lung 
tissue in the isolated perfused mouse lung model (65). As a mechanosensitive protein 
amphiregulin is already induced by the slicing process during the preparation of PCLS. 
A maximum induction was found 4h after the slicing process. After 24h amphiregulin 
induction was reduced to a big extent, therefore we tried if it was possible to induce it by 
stretching the PCLS. Four hours of stretch did not induce amphiregulin RNA induction 
in comparison to 4h clamped but unstretched PCLS or to control PCLS. There was a 
trend in reduction of amphiregulin RNA expression in the stretched PCLS, possibly 
indicating that stretching of the PCLS may be closer to the physiological conditions of 
the lung than static organ culture (Fig. 4.34).
4.4.4.3. Treatment with ML-7
ML-7 has been shown to reduce the maximum induction of amphiregulin after the 
slicing process. Therefore, we treated PCLS with ML-7 during and 4h after the slicing 
process. 24h after the slicing process PCLS were stretched or clamped for 2h in the 
bioreactor and compared to non-stretched PCLS (Fig. 4.35). 
The stretching period was reduced to 2h to increase the number of experiments per 
day. In addition, amphiregulin has been shown to be induced 1h after slicing (data not 
shown) and 2h after overventilation in the IPL mouse model (unpublished data, M. 
Figure 4.34:  Amphiregulin RNA 
expression in PCLS. PCLS were 
cultured for 24h and dynamically 
stretched for 4h at 35 mbar. 
Stretched PCLS were compared to 
4h clamped and control (PCLS in 
culture) PCLS. Data are given as 
mean ± SD, n = 3. Data was Box-
Cox transformed and analysed by 
the Tukey Hsd test.
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Barrenschee). No difference in amphiregulin induction was found between the control 
and the stretched PCLS (Fig. 4.35). 
4.4.4.4. Distension of PCLS after 72h
To possibly diminish the gene induction by time, experiments were performed 72h 
after the slicing process. Viabiliy of the PCLS was verified by MTT-test (Fig. 4.36).
Compared to PCLS after 24h, amphiregulin expression in PCLS was reduced 72h after 
the slicing process (Fig. 4.37). Both clamping or clamping and stretching PCLS for 
0.5h induced amphiregulin to a comparable amount. After 1h amphiregulin was still 
Figure 4.35:  Amphiregulin RNA expression in PCLS treated with ML-7 
during and 4h after the slicing process. 24h after the slicing process PCLS 
were either clamped or stretched for 2h at 35 mbar in the bioreactor and 
the amphiregulin expression was compared to control PCLS. Data are 
given as mean ± SD, n = 3. Data was Box-Cox transformed and analysed by 
the Tukey Hsd test.
Figure 4.36:  Viability of 
PCLS after 72h in culture 
measured by MTT-test. PCLS 
cultured for 72 h (black bar) 
show a significantly higher 
mitochondrial activity than 
detergent treated (grey 
bar) PCLS. Data are given as 
mean ± SD, n = 3. Data was 
Box-Cox transformed and 
analysed by the Students 
t-test, p-values < 0.05 were 
considered significantly 
different (*).
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expressed in clamped PCLS, whereas 1h stretch significantly reduced its expression to 
control levels (Fig. 4.37).
4.4.4.5. Treatment with Dexamethasone
Dexamethasone is a potent anti-inflammatory and immunosuppressive agent. To 
exclude any effect of a possible pro-inflammatory response initiated by the slicing 
process, we added dexamethasone during the slicing process and during the first 4h 
of incubation. Viability of dexamethasone-treated PCLS was determined after 72h in 
culture in comparison to detergent (Triton-X 100)-treated PCLS. No difference between 
Figure 4.38:  Mitochondrial 
activity in PCLS 72h after the 
slicing process. MTT formation 
was determined in control 
(white bar), dexamethasone 
treated (black bar) and 
dexamethasone + detergent 
treated PCLS (grey bar). 
Data are given as mean ± 
SD, n = 3. Data was Box-Cox 
transformed and analysed by 
the Tukey Hsd test. * indicates 
significant differences of 
control to detergent-treated 
PCLS; + indicates significant 
differences between 
dexamethasone- and 
detergent-treated PCLS.
Figure 4.37:  Amphi regu l in 
RNA expression in PCLS 72h 
after the slicing process. Slices 
were clamped (black bars) 
or stretched dynamically 
(grey bars) for 0.5 and 1h in 
the bioreactor at 35 mbar. 
Data are given as mean ± 
SD, n = 3. Data was Box-Cox 
transformed and analysed by 
the Tukey Hsd test, p-values 
< 0.05 were considered 
significantly different (*).
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dexamethasone treated and control PCLS was observed in the mitochondrial activity 
after 72h, indicating no influence of dexamethasone on viability of PCLS for at least 
72h. In contrast, no mitochonadrial activity was observed in detergent treated PCLS 
(Fig. 4.38).
After 72h of incubation dexamethasone-treated PCLS were clamped or stretched 
in the bioreactor. Clamping and Stretching for 0.5 and 1h resulted in a comparable 
amphiregulin induction. No differences were observed between clamped and 
stretched PCLS (Fig. 4.39).
Figure 4.39:  Amphiregulin 
RNA expression in 
dexamethasone treated 
PCLS 72h after the slicing 
process. PCLS were either 
clamped (grey) or stretched 
(white) for 0.5h or 1h in 
the bioreactor. Control 
dexamethasone-treated 
PCLS are shown as black 
bar. Data are given as 
mean ± SD, n = 4. Data was 
Box-Cox transformed and 
analysed by the Tukey Hsd 
test, p-values < 0.05 were 
considered significantly 
different (*).
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5. Discussion
Oxygenation of the blood and removal of carbon dioxide from it is the most 
important function of the lung. To provide an adequate area for gas exchange, 
the interior surface of the lung has much larger dimensions than its outer surface 
area. Although the lung is situated inside the body, most of it is permanently in 
contact with the enviroment. On such a large surface, many kinds of stresses can 
occur and damage the lung. Stress can appear chemically in terms of toxins or 
allergens, or it can appear in form of physical damage, by overstretching the tissue. 
At the same time the lung is a very complex organ with more than 40 different cell types. 
Most stress models are either too complex, considering the whole organ, or too simple 
by studying only one cell type. Using precision-cut lung slices as a stress model has 
several advantages. They provide a relatively intact microanatomy of many different 
cell types and possess an extracellular matrix. Originally developed for toxicological 
research, lung slices have recently become an important tool for pharmacological and 
mechanistic studies. The advantage that many slices can be prepared from a single 
donor lung is associated with the possibility to prepare PCLS of different parts of the 
lung. It is possible to prepare PCLS with focus on large or small airways or vessels, 
and it is also possible to prepare tissue slices of different sizes. At present, PCLS with a 
diameter of up to 14 mm can be prepared with a Krumdieck tissue slicer. Another fact 
which makes PCLS attractive is the possibility to prepare them from different species. 
Amongst others, this provides the opportunity to compare animal tissue to that of 
human lungs. Comparison between different species has been realised mostly to study 
airway pharmacology (218) with good prospects to apply this also for other studies. 
Another advantage is the possibility to compare PCLS to in vivo experiments of the 
same species in order to reduce the number of in vivo experiments. Promising results 
have been shown in mouse PCLS by comparison of pulmonary resistance in vivo and 
maximum contraction in vitro (110). 
In this study PCLS were used as a model for different kinds of stress in the lungs. Stress 
was applied in form of chemical allergens and in form of tissue injury by slicing and 
stretching. In general two aspects were adressed in this work. Firstly, two new methods 
were developed. Sheep PCLS were introduced as a model to study pharmacology of 
broncho- and vasoconstriction. This study also established and characterised a new 
stretch model adressing overexpansion of lung tissue during mechanical ventilation. 
To this end, PCLS were stretched in a bioreactor to study mechanical and biological 
consequences. Finally, PCLS were used to measure responses like bronchoconstriction 
and gene expression to stress stimuli, such as chemical allergen challenge or slicing. 
79
5. Discussion
5.1. The model of sheep PCLS
Sheep are considered a useful model in lung research. Sheep have been used as models 
for asthma, COPD or cystic fibrosis (3). In addition, several studies of ALI or ARDS have 
been performed in sheep (223; 285). A specific model of lung research is represented 
by the sheep pulmonary adenomatosis model, which studies retrovirus-associated 
lung cancer (192). Studies on preterm sheep were done especially in the context of 
chorioamnionitis, a risk factor for bronchopulmonary dysplasia in preterm infants (40). 
In the present study we describe the establishment and characterisation of sheep PCLS, 
prepared from agarose-filled lungs with a Krumdieck tissue slicer. Before, only one 
other study was published in 1967 describing the preparation of sheep lung slices from 
lung explants (44). In that study, slices were cultured for only 3h, and used to measure 
acetate incorporation into phospholipids and fatty acids. Other studies with sheep were 
accomplished in vivo or by using in vitro experimental set-ups, such as bronchial- and 
tracheal rings or lung parenchymal strips (165; 178; 236). Mehta et al. investigated the 
effect of xanthine derivatives on tracheal rings of preterm lambs. Interestingly, caffeine 
and theophylline had differential effects on preterm sheep airway smooth muscle 
cells. In contrast to precontracted adult airway smooth muscle cells, which are relaxed 
by addition of xanthine derivatives, only theophylline had a relaxing effect on preterm 
sheep airway smooth muscle cells (165). Others used tracheal strips and bronchial rings 
in the organ bath technique, to determine contractile responses of large and small ovine 
airways to thiopental (178). Functional innervation of sheep airway smooth muscle 
cells was measured in tracheal segments, bronchial rings and lung parenchymal strips 
(236). This is the first study to exam airway and pulmonary vascular responses in sheep 
in PCLS. Our aim was to establish sheep precision-cut lung slices to study single airway 
and vessel pharmacology in this species. In contrast to isolated trachea or lung strips 
the microanatomy around the smooth muscle is mostly preserved, which stabilises 
the airway and makes it unnecessary to apply an external preload to the lung slice. 
Therefore the smooth muscle can contract in a way more physiological way than isolated 
tracheal- or bronchial rings, because preload directly influences the contractility. 
Non-laboratory animals with body weights in the range of humans are often 
considered to be more relevant to the human pathophysiology than smaller animals. 
Additionally, the maturation of sheep lungs is more similar to the maturation of human 
lungs than are rodent lungs. That favors this species especially for the examination 
of preterm animals. In the present study, sheep PCLS of preterm and adult sheep 
were compared. This would be difficult in rodents, because preterm rodent lungs 
are too small to yield PCLS. The use of preterm sheep limits the supply with lungs, 
because sheep are seasonal breeders and give birth only once a year, usually in 
spring. Therefore, in the present study, only a limited number of PCLS could be tested. 
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PCLS of adult and preterm sheep were viable up to 72h in culture, as assessed by 
mitochondrial activity. However, preterm sheep PCLS showed a significantly higher 
mitochondrial activity than adult sheep PCLS. The airway size in both adult and 
preterm sheep was comparable, in the same way than the size of the PCLS themselves. 
Therefore, we had age-related size differences, because smaller airways were prepared 
from adult sheep than from preterm ones, in order to measure airways of comparable 
size. Preparing PCLS from different parts of the lungs may have influenced the 
mitochondrial activity. Another reason could be a general higher mitochondrial activity 
in preterm sheep lungs. During transition from fetal to neonatal life cellular energy 
requirements are at maximal rates. Brown adipose tissue is enriched during gestation, 
which is rich of mitochondria, especially at the time of birth (175; 195). MTT formation 
is dependent on mitochondrial activity which may explain the higher reduction rates 
in the preterm sheep. 
5.1.1. Airway responses of sheep PCLS
Sheep have been used as an asthma model because of several similarities to humans. 
This includes the immune status, airway inflammation after allergen challenge, the 
airway response and the AHR (3). Six different mediators which are known to act as 
bronchoconstrictors, were used to characterise bronchoconstriction in sheep PCLS 
(217). Compared to other species, the reactivity to methacholine was in the same range 
as observed in human and guinea pig PCLS (Table 5.1). In contrast to human PCLS, sheep 
PCLS showed responsiveness to serotonin. The EC50 value for serotonin of 122 nM was 
in the same range as in guinea pig PCLS (69 nM). In vivo, ED50 values of methacholine 
and serotonin in anaesthesised guinea pigs are 3 mM and 7 μM, respectively (121). The 
in vivo setup measures whole lung responses by pulmonary inflation pressure while 
in PCLS single airways are measured directly. Additionally, the form of application – 
inhaled versus solution – differs in the experimental setups. Therefore a comparison 
of the absolute values is not reasonable. Interestingly, methacholine is more effective 
than serotonin in vivo, whereas in PCLS serotonin was the more potent mediator 
compared to methacholine. Surprisingly, sheep PCLS - just as mouse airways - did 
not react to histamine, while airways in guinea pig and human PCLS respond to 
histamine. In vivo, sheep airway responsiveness to histamine was observed (3). In vitro, 
sheep airway smooth muscle strips and bronchial rings also reacted to histamine, but 
dependent on airway size. Only large airways contracted, smaller airways even relaxed 
in response to histamine (178; 236). Because we studied only PCLS with relatively small 
airways, this could explain the unresponsiveness in PCLS compared to in vivo and in 
vitro experiments. Endothelin-1 EC50 values of guinea pig, rat, mouse and sheep PCLS 
were comparable (Table 5.1). In contrast to guinea pig and human PCLS, the response 
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of sheep PCLS to leukotriene D4 was rather weak with contractions starting at 100 nM. 
Also the response to U46619 in sheep showed a weak contraction at concentrations 
of 10 µM in sheep PCLS. Taken together, the airway response pattern of small 
airways of sheep PCLS to endogenous mediators differs from that of human airways 
studied under comparable conditions (218). In vivo a response to leukotriene D4 and 
histamine was observed. Like in guinea pig PCLS there was a response to serotonin, 
which is not observed in human PCLS (218). As with mouse and rat PCLS (108; 304), 
the response to histamine and leukotriene D4 was either not observed or only weak.
Preterm birth may have effects on airway function, because the lung is not fully 
maturated. Snibson et al. found that preterm sheep had a higher baseline pulmonary 
resistance and a greater airway response to bronchoconstrictors than normal sheep 
(242). This is the first time that bronchoconstriction of preterm and adult sheep 
airways in response to bronchoconstrictors was compared. We found different EC50 
values for methacholine and serotonin. In contrast to the in vivo study by Snibson et al. 
preterm sheep airways were less reactive than adult ones to both mediators. This may 
be explained by a different contractile response of newborn airway smooth muscle 
cells. In in vitro experiments, isolated adult airway smooth muscle cells show a faster 
maximum shortening velocity than cells from newborn sheep (139). 
Responsiveness to endothelin-1 showed no difference between adult and preterm 
sheep PCLS. In isolated airway smooth muscle cells the influence of ageing was 
dependent on the species investigated. Whereas the endothelin-1 response was 
influenced by the age of the donor in rabbit and rat cells, guinea pig cells showed no 
difference by ageing (92; 204). EC50 values of guinea pig and sheep PCLS were also 
comparable (Table 5.1), indicating similar responses to endothelin-1 in both species. 
With the exception of the response to leukotriene D4, where preterm sheep PCLS 
showed a higher maximum contraction, they responded generally weaker than adult 
sheep PCLS (Table 5.1). This difference could be due to the age-related size difference 
of the airways of preterm and adult sheep. This is consistent with the different airway 
size related responses which were demonstrated in rat PCLS before (155). 
Table 5.1:   EC50 values of mediators in PCLS of different species. 
Adult sheep Newborn 
sheep
Human (218) Guinea 
pig (218)
Rat (12; 
153; 155)
Mouse (108)
Methacholine 70 nM 187 nM 234 nM 231 nM 640 nM 1500 nM
Serotonin 122 nM 377 nM unresponsive 69 nM 100 nM 2000 nM
Endothelin-1 16 nM 16 nM - 9.6 nM 22 nM 50 nM
Histamine unresponsive unresponsive 2170 nM 217 nM - unresponsive
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5.1.2. Vascular responses of sheep PCLS
Another advantage of the PCLS model is the possibility to study the response of airways 
and vessels in one slice. Pulmonary arteries are located close to the airways and can 
be observed at the same time. As with airway responses there was no difference in the 
response of adult and preterm pulmonary arteries to endothelin-1, which contracted 
with an EC50 value of 19 nM. The constriction was therefore in same range as the 
airway response. These EC50 values are comparable with those in guinea pig PCLS 
(218). Responses to endothelin-1 in isolated pulmonary vessels of adult sheep, fetal 
and newborn sheep have been studied before by Toga et al. (259). They found a dose-
dependent contraction to concentrations of 1 nM to 1 µM endothelin-1 in vessel rings. 
Both, arteries and veins of adult sheep lungs were more sensitive to endothelin-1 than 
those of fetal and newborn sheep. Additionally, they found a greater sensitivity of 
veins to endothelin-1, compared with arteries (259). In adult and preterm sheep PCLS, 
we observed contractions of pulmonary arteries in the same range of endothelin-1 
concentrations, but no differences between adult and preterm sheep PCLS were found. 
This could be a result of the different models used. Toga et al. isolated vessel rings 
whereas we used PCLS with relatively intact tissue around the vessel. Additionally, we 
observed only pulmonary arteries. In the study of Toga et al. the arteries were less 
responsive than veins (259).
In contrast to airway responses, adult and newborn sheep vessels responded likewise 
to U46619, while there was no response to leukotriene D4, apart from a slight reaction 
of preterm sheep PCLS. U46619 was used as a precontracting agent ex vivo in lambs, 
especially with regard to pulmonary hypertension (260; 289). In vivo, the age-
dependent response to leukotriene D4 was investigated in lambs of different ages. This 
was tested via bolus injection of 0.01-1 µg/kg leukotriene D4 into the main pulmonary 
artery while pulmonary blood flow as well as aortic, pulmonary artery, left and right 
ventricle pressures were monitored. A vasoconstriction increasing with age, was 
observed for leukotriene D4 (50). These results were not found in PCLS, which showed, 
if at all, a rather weak response of preterm sheep arteries. This could have different 
reasons. Firstly, no preterm sheep arteries were examined in the study mentioned 
above (70), only lambs at the age of 1.5 days and 7 days. Secondly, the contraction 
was measured indirectly via vessel pressures and blood flow. Those in vivo studies may 
therefore provide other physiological characteristics than the PCLS model.
Taken together, the sheep PCLS provide a novel and useful model to measure vascular 
responses of single vessels in response to different vasoconstrictors. 
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5.2. Effect of allergens to mouse PCLS
The knowledge of potential toxicants, among them potential allergens, is quite limited 
and has received new awareness by the European Union Regulation REACH (Regulation, 
Evaluation, Authorisation and restriction of CHemicals), which was released in 2006 (74). 
REACH addresses the production and use of chemical substances, and their potential 
impact on both human health and the enviroment. Companies that manufacture or 
import substances in quantities of one ton or more per year have to register them in 
the European Union. This increases the need for easy-to-handle screening methods in 
animals, which should account for the 3R (replace, reduce, refine) concept (226). 
Our experiments were accomplished in mouse PCLS, because murine models are well 
studied and characterised. TMA and DNCB were used as examples of typical respiratory 
and dermal sensitisers, respectively. Both substances have been used in various studies 
before and are therefore well characterised with respect to their allergic potential. In 
general both substances induced a Th2 dependent IL-4 expression, which was more 
distinct in TMA sensitised mice (14). The cytokine profile induced in lymph node 
assays was different for both, TMA and DNCB, with a mixed induction of a Th1 and Th2 
response (60). An increase in serum IgE was found in TMA and in DNCB sensitised mice 
(93; 278), with a stronger induction in TMA sensitised mice (14). The sensitisation with 
TMA and DNCB in our experiments was successful as approved by the determination 
of IgE serum concentrations. The present study was realised in collaboration with the 
group of A. Braun (ITEM, Hannover), who measured IgE concentrations in the serum 
of sensitised mice and lung functions in vivo. The results are in line with the studies 
mentioned above (93; 278), also displaying an increase in IgE serum concentrations 
(Figure 5.1.).
Figure 5.1:  Total IgE serum levels determined in blood samples collected by retroorbital bleeding 
on day 13 after the start of sensitisation. Mice were sensitised by TMA, DNCB or acetone as vehicle 
control. Experiments were performed by Maja Henjakovich (Hannover). Data are given as mean 
± SEM; n = 5 –15. Data was compared by the two-sided, unpaired t-test. The data are taken from 
Reference (110).
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The dermal application route was chosen because it is the relevant route of sensitisation. 
Former studies demonstrated the development of a respiratory allergy with a typical 
Th2 immune response in mice after dermal exposure and respiratory challenge with 
TMA (14; 61). Furthermore, the sensitisation in humans with TMA may originate in 
dermal exposure (18).
In the present study we compared invasive in vivo lung function measurements with 
bronchoconstriction ex vivo in PCLS. The aim was to establish PCLS as an alternative 
method to in vivo experiments. In agreement with the 3R concept, the use of PCLS 
avoids stress for the individual animal, since experiments are performed ex vivo and it 
allows reducing animal numbers by using several slices from one animal. At least 10 
ideally cut PCLS can be obtained from one mouse lung (108; 111), which, in addition 
to construction of full dose-response curves for airway contraction, allows the 
comparison to control PCLS from the same animals. It is assumed that animal numbers 
can be reduced by a factor of 3 to 10 compared to full in vivo studies (110). Our results 
indicate that PCLS and in vivo data do concur well.
5.2.1. Early allergic response in TMA and DNCB sensitised mice
TMA and DNCB sensitised mice have been shown to exhibit an EAR after challenge 
with TMA and DNCB (278). In the present study neither in vivo nor ex vivo an EAR was 
observed. Vanoirbeek et al. measured the EAR in vivo by the obsolete PenH method 
(278), in contrast to the invasive method we used (87). PenH is no reliable measurement 
of lung resistance and does not distinguish between the upper and the lower airways, 
which becomes relevant with regard to allergic rhinitis. Humans who inhaled TMA 
dust developed allergic rhinitis (90), suggesting a reason for altered responses with the 
PenH method. It is impossible to correlate airway resistance with PenH measurements 
(128; 147; 166). In principle, the detection of EAR in invasive pulmonary function tests 
in mice is possible, as it was shown for Aspergillus fumigates antigen sensitised mice 
(72; 87). However, preexisting inflammation in the lung seems to be a requirement for 
EAR in mice, so possibly a single TMA provocation is not sufficient to induce an EAR. In 
publications dealing with ovalbumin sensitised mice, an EAR is also lacking after single 
provocations (183; 314). Other species, such as the guinea pig, show an EAR even in 
non-sensitised animals in response to inhaled TMA dust (138). This may be another 
example for the notion that guinea pigs may reflect humans better than rodents (218). 
We used allergen doses which were not toxic in PCLS. Our doses were  10-fold lower than 
doses in other studies (278), excluding any irritant toxic effects by the allergen itself. 
This may also explain the absence of stronger inflammation and EAR in comparison to 
other studies.
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5.2.2. Airway hyperresponsiveness in TMA and DNCB sensitised mice
The in vivo and ex vivo responsiveness to methacholine 24h or 16h after allergen 
challenge was significantly increased in TMA-sensitised mice and in PCLS from those 
animals, demonstrating that TMA caused a marked AHR. DNCB-sensitised animals 
and lung slices from DNCB-treated mice did not show clear signs of AHR. Although 
the nominal differences between TMA and DNCB groups to their vehicle control were 
similar, only the difference between TMA and control reached statistical significance. 
Therefore, this method may not be suitable for the differentiation between skin and 
respiratory sensitsers at this stage of development. Because the AHR occured in 
vitro, the influx of inflammatory cells can be excluded as a contributing factor, which, 
amongst other mechanisms, is thought to play a role (149). Resident mast cells, 
eosinophils and neutrophils are possible mediators of the AHR. Another potential 
mechanism may result from smooth muscle priming leading to a direct contraction 
(109; 110). It has been reported before that TMA sensitisation leads to an increased 
methacholine responsiveness in mice while DNCB sensitisation results in diminished 
AHR compared to TMA or does not lead to a response at all (278). This is in line with studies 
demonstrating that DNCB sensitisation does not result in respiratory allergenicity and 
is defined mostly by a Th1 response (62). At least the influx of T lymphocytes seem to be 
not essential for AHR, judged by the absence of these cells in the ex vivo experiments. 
An influence of T lymphocytes could only result from preliminarily migrated cells.
In summary, the EAR and AHR in vivo correlated well with those in PCLS obtained 
from sensitised animals. We were able to show that TMA induces allergic sensitisation, 
inflammation of the respiratory tract and airway responsiveness to methacholine in 
vivo and ex vivo. In general, airway sensitising effects of LMW allergens may be studied 
in PCLS.
5.3. Stretching of PCLS in the bioreactor
We describe a new experimental in vitro model for studying mechanostimulation of 
lung tissue with relatively intact microanatomy under cell culture conditions. We have 
shown that PDMS is a suitable material to support PCLS. In the bioreactor lung tissue 
can be stretched cyclically by about 30 % longitudinally and latitudinally for at least 
4h without causing cell death. 70 µM below the surface of the slices, multi-photon 
microscopy showed a comparable amount of dead cells in control and stretched slices. 
In contrast, confocal microscopic images showed relatively high numbers of dead 
cells in stretched and control PCLS (Fig. 4.32). The confocal images were recorded in 
a depth of approximal 40 to 50 μm. Dead cells may therefore be due to the relatively 
close distance to the surface. The difference between the two methods may also be 
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explained by the different stainings. However, the difference to completely dead PCLS 
shown by detergent treated PCLS is obvious and the viability of stretched PCLS was 
confirmed by mitochondrial activity.
To study PCLS in the bioreactor, several modifications of the bioreactor were necessary. 
The dimensions of rat lungs permit a maximum PCLS diameter of 14 mm only, which 
mandated downsizing the bioreactor inserts from the 30 mm that were used in the 
original version of the bioreactor (232). To support the tissue in the bioreactor, we 
used 30 µm thick PMDS-membranes, which are about a factor 3 to 6 more pliant than 
polyurethane or latex membranes employed originally in the bioreactor (232).
Others have used the Flexercell system to stretch cells in culture (15), where silicon 
membranes with a thickness of 250 µm are used. In contrast to the Flexercell set-up, 
there is no frictional energy dissipation inside the bioreactor (depending on the viscous 
properties of the membrane). This allows a precise control of the deflection amplitude 
and thus of the strain which is applied to the tissue or the cells under investigation. In 
addition, in its present form the Flexercell system does not allow to mount living slices. 
Stretched PCLS as an in vitro model have several advantages. First, the slices can be 
viewed under the microscope, which allows studying of alveolar regions during the 
stretching process. In combination with multi-photon microscopy this will allow to 
image the stretched lung tissue in 3D and to follow critical signalling responses such 
as calcium fluxes. Secondly, up to 20 usable slices can be prepared from one rat lung. 
Since the slices are of a defined diameter and thickness experimental conditions can 
be adjusted individually. Third, PCLS are viable for at least three days (218) which will 
permit to study the effects of different ventilation strategies on lung tissue over time. 
Fourth, PCLS provide an intact microanatomy consisting of different lung cell types 
and extracellular matrix which is lost in cell culture models consisting of only one cell 
type. Fifth, PCLS can also be prepared from human tissue (218; 303) which will offer 
the unique opportunity to study the response of human tissue to various degrees of 
stretch.
5.3.1. Applied stretch in our model
Material properties applied in the FE model were selected to fit the directly measured 
displacements (Fig. 4.26). The FE simulation allowed quantifying the associated strain 
distribution in the lung slices (Fig. 4.27). In the longitudinal direction, the stretch 
distribution seems to be remarkably homogeneous. Latitudinal stretches of the 
membrane-tissue construct were continuously increasing from the periphery towards 
the center (about 35 %). The FEM data compare rather well to the increase in perimeter 
of single alveoli close to the center that were determined by direct measurement under 
the microscope. At 35 mbar, the combination of longitudinal and latitudinal stretch was 
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24.9 ± 4.1 %, a degree of stretch that is generally considered to be relevant for possible 
side effects caused by mechanical ventilation (198). It should be noted though that 
the baseline stretch of the slice mounted on the membrane to which the stretch is 
normalised is not exactly defined; however, once the agarose has been washed out 
the only forces in the slices that are keeping the alveoli open are the tethering forces 
of the tissue. Therefore, it seems reasonable to assume that the unstretched lung slices 
correspond to a deflated lung, although the degree of deflation is not known.
Recently, Perlman and Bhattacharya demonstrated that the perimeter of superficial 
alveoli 20 µm below the rat lung surface increased by about 14 % if the lung volume 
was increased from 50 % TLC at 5 mbar up to 85 % TLC at 20 mbar (198). Thus, in 
terms of perimeter increase the compliance in two dimensions was 14 % / 15 mbar 
= 0.93 % / mbar. Calculation of the slope in Fig. 4.29 D yields in 0.69 % / mbar. This 
may suggests that mechanical lung properties in both settings are comparable, 
although there are several caveats. First, the mechanics of tissue distension in two 
and three dimensions is different. Second, it is not clear which level of lung volume 
is represented by the mounted slices at baseline (0 mbar). However, as long as the 
relation between alveolar pressure and perimeter is linear (as it was in this study and 
in (198), the slope should be independent of any particular lung volume. And third, our 
model lacks surface tension, although this would not alter the strain state but only the 
inner stress state of the tissue. Taken together, it remains to be determined whether 
the comparable slope of the pressure/perimeter relationship in the slices and in the 
intact organ is a coincidence or reveals a typical behaviour of lung tissue. 
In the past, calculations of the strain that is generated during distension of lung 
tissue have been based either on the analysis of fixated lung tissue specimen (267), 
of superficial lung regions (198) or on cells in culture (15; 54). All these methods have 
their specific advantages and shortcomings. Tissue fixation is prone to fixation artefacts 
and provides images of dead tissue only. The analysis of superficial alveolar regions 
offers problems with identifying the factual imaging plane and can only analyse the 
special case of subpleural alveoli; here the present work suggests that the mechanical 
behaviour of those superficial alveoli is representative for alveoli in general (see 
above). And finally, lung cells in culture – although easy to stretch and study – do only 
partly reflect the properties of real lung tissue with its many different cell types and its 
extracellular matrix. In comparison to the models discussed above, one advantage of 
the present model is that it uses viable lung tissue with a relatively intact microanatomy 
that is not derived from the lung surface. Thus, this model complements the already 
available methods. A wide variety of techniques are available to study responses in 
precision-cut lung slices including videomicroscopy to study airway smooth muscle 
responses (153), ciliary beating (303), alveolar distension (this study), calcium fluxes 
(20), as well as gene expression and cytokine signalling (154). Thus, in a next step, this 
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model will allow to establish a quantitative relationship between mechanical forces 
and cellular response in the lung.
A comparable model has been described with neonatal tissue explants and has yielded 
important insights into understanding the processes of the lung expansion at birth 
(275). However, that model was based on the ability of the neonatal tissue to grow into 
and adhere to a medical sponge material. Experiments with precision-cut lung slices 
showed that adult tissue is not capable of making contact with sponge materials in 
the same manner and therefore the lung tissue needed to be fixated mechanically. In 
addition, experiments where the tissue was glued to the membrane resulted in a non 
homogeneous extension of the tissue and may activate cells in the tissue. 
Hysteresis was not observed in our model which may have different reasons. Firstly, 
we eliminated the air-liquid interface by covering the PCLS in the bioreactor with 
medium. Incubation also depleted the surfactant from the PCLS. Secondly, we did our 
displacement measurements statically, which could have eliminated hysteresis.
5.3.2. Influence of collagen
Lung tissue exhibits linear viscoelastic and nonlinear behaviour, dependent on several 
structural components, such as collagen. Collagen fibers in the extracellular matrix 
give lung tissue its tensile strength. It is thought to limit lung extensibility at high 
Figure 5.2:  Strain-stress curve of a PCLS stretched in a tension machine. PCLS was measured before 
(red) and after (green) collagenase treatment. Experiment was performed by S. Rausch (München).
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volumes, therefore protecting the lung against overdistension (161). Strain-stress 
curves of lung parenchyma normally show a linear interval at low strains passing into 
a nonlinear region, probably defined by the tensile strengh of the collagen fibers, at 
higher strains. After collagenase treatment, the strain-stress curves show a right shift of 
the curve resulting in a softer tissue (310). Without collagen, no tensile strength limits 
the distension of the tissue. Hence, the slope and the elastic modulus after collagenase 
treatment must be smaller.
This was confirmed by the group of W. Wall (München) by stretching PCLS in a tension 
machine (Fig. 5.2). 
In the bioreactor we observed a shift towards the membrane curve at a displacement 
of 2 mm. Most of the PCLS ripped between a displacement of 1.5 and 2 mm, indicating 
rather a disintegration of the PCLS before the altered material properties of the tissue 
become apparent. Disintegration of the PCLS in such a small range indicates that the 
stretch applied is greater or at least the strain in the bioreactor is different from the one 
applied in the tension machine. The stretch applied in the bioreactor is biaxial, which 
complicates the comparison with the uniaxial tension applied by the tension machine. 
However, our method concerning displacement readings may not be as sensitive as 
tissue stretched in a tension machine.
Regarding to the stretch distributions, the bioreactor applies stretch inhomogeneously, 
which may reflect the in vivo situation closer than homogeneous stretch. Taken together, 
these data demonstrate that tissue properties are altered by collagenase treatment. 
However, the current technical equipment of the strain-stress measurements is not 
ideal to measure material properties following collagenase treatment.
5.4. Gene induction in PCLS
5.4.1. Amphiregulin induction in PCLS
We exposed PCLS to mechanical stress by stretching them in the bioreactor. To 
investigate the biological consequences of the stretch, we examined gene induction 
in stretched PCLS. The most favoured gene was amphiregulin, which has been proven 
to be a promising candidate gene in mouse IPL experiments (65). Its induction 
specifically by stretch and not by LPS makes it an ideal stretch marker. Unfortunately, 
amphiregulin was already upregulated by the slicing process, which obviously acts as 
mechanical stress as well. Amphiregulin has been shown to be stress sensitive before, 
an upregulation can be triggered for example by mechanical compression of bronchial 
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epithelial cells (47). It has been also shown to participate in wound healing in colonic 
mucosa cells (117), which could be also its function in sliced lung tissue. 
To measure amphiregulin expression especially induced by stretch, it was our aim to 
decrease its basal expression induced by the slicing process. One idea was to culture 
PCLS at 37°C for longer time periods (up to 72h) to reduce the basal expression. 
However, also the expression of amphiregulin decreased during the incubation, even 
after 3 days it could not be induced by stretch in the bioreactor. One explanation could 
be that the PCLS were held in static culture. Stretch of 1h even seemed to reduce the 
amphiregulin induction, which may be due to the fact, that the lung in its normal 
environment is stretched all the time. Therefore the static culture conditions may be 
a stress factor for the PCLS itself. This could be solved by the adjustment of culture 
conditions, for example by culturing them in the roller culture system described 
before (153). In that system the PCLS are held at the air-liquid interface and are moved 
constantly. This could be further improved by a basic stretch tonus applied to the PCLS 
during culture, mimicking the in vivo situation.
Another idea was to keep the PCLS at 4°C after the slicing process, to avoid activation 
on transcriptional level and thus reduce the initial gene induction triggered by the 
slicing process. We incubated PCLS for different time spans at 4°C and investigated the 
induction at 37°C afterwards. Twenty hours at 4°C did not reduce the induction, but 
44h had a significant influence. This indicates a “memory” of the PCLS, the induction 
is only delayed. Longer incubation periods at 4°C may contribute to a degradation of 
inflammatory mediators released during the slicing process and therefore reduce the 
inflammatory response after 44h at 4°C. However, the induction was still comparably 
pronounced to the 24h induction after normal incubation. 
PCLS were also treated with different inhibitors of transcription, translation and 
signalling pathways. Aside from trying to reduce the basal amphiregulin induction, it 
was our aim to get more information about the mechanism by which amphiregulin is 
upregulated by the slicing process. Actinomycin D, DRB and cycloheximide are known 
inhibitors of transcriptional processes (41; 100; 256). All of them were able to inhibit the 
RNA induction. Actinomycin D, DRB and apicidin are known to affect the RNA synthesis 
directly by intercalating into the DNA, inhibiting the casein kinase 2 and inhibiting the 
histone deacetylase, respectively. Apicidin seems to act irreversible (100), which was 
also observed with actinomycin D, but not with DRB. Interestingly cycloheximide also 
reduced amphiregulin induction, although it is a translational inhibitor and should 
not influence RNA levels (188). An explanation could be a feedback mechanism, by 
the newly synthesised amphiregulin protein. However, a feedback mechanism of 
amphiregulin has not been described up to now.
The tyrosine kinase signalling system has been shown to be important in the induction 
of amphiregulin (235), as confirmed in our system. In addition we found an influence 
of the cytoskeleton, namely by inhibition of the MLCK. Both MLCK and tyrosine kinases 
91
5. Discussion
seem to play an important role in endothelial cells in cytoskeletal rearrangements 
after shear stress (23), another type of mechanical stress. Also airway smooth muscle 
cells, which are subjected to mechanical stretch exhibit increased MLCK quantities 
(241). Consequently, MLCK and tyrosine kinases play a role in responses to mechanical 
stretch in different cell types and may therefore also be important for the mechanical 
stress induced upregulation of amphiregulin in PCLS. Inhibition of ROCK had no effect 
on amphiregulin; therefore it is very unlikely to be involved in amphiregulin induction. 
However, models of lung imflammation and lung injury showed an activation of ROCK 
and preventive effects of Y27632 (26; 130; 168). Blocking of the MLCK pathway looks 
promising; therefore it could be interesting to add both inhibitors, ML-7 and Y27632, 
looking for a synergistic effect. Another major molecule, which may be involved in 
mechanotransduction, is calcium. It has been shown to be involved in signalling 
by stretch-activated ion channels (96). In lung fetal alveolar epithelial cells calcium 
mobilisation seems to be a key molecule to activate early response genes after 
mechanical stretch (54). Calcium may play a role in the amphiregulin induction. We 
reduced calcium in the medium during the slicing process and for 4h after it. There was 
a small reduction in the amphiregulin induction at 0h and 4h after the slicing process. 
Because calcium is a fast acting mediator which is elevated during seconds in the 
cytoplasm our method may not be significant. Firstly, we did not deplete the calcium 
in the medium, which means there could be still enough calcium left for signalling. 
Secondly, the direct measurement of calcium for example by multi photon microscopy 
would be more adequate. However, neither the partial depletion of calcium nor 
blocking of calcium channels did reduce amphiregulin expression. 
The acid sphingomyelinase pathway has received attention in many pulmonary 
diseases, such as COPD, cystic fibrosis and ALI. As initiator of ceramide-mediated 
signal transduction it may also play a role in stress-induced cell death (240). Especially 
sphingosine-1-phosphate, a mediator of the acid sphingomyelinase pathway, has 
been shown to be barrier protective on the alveolar and vascular level in murine lungs 
subjected to mechanical stress (160; 196). Sphingosine-1-phosphate may enhance 
amphiregulin induction which could be also a solvent effect. The solvent reduced the 
amphiregulin induction 4h after the slicing process. Compared to control PCLS there is 
no effect of sphingosine-1-phosphate. This is in line with the fact, that imipramine, an 
inhibitor of the acid sphingomyelinase, did not affect the induction of amphiregulin, 
suggesting the acid sphingomyelinase is not involved in this process. 
Taken together, neither the reduction of temparature during incubation or at later 
time points nor the addition of inhibitors resulted in a satisfying reduction of the 
amphiregulin expression that is induced by the slicing process. A combination of 
inhibitors may be promising, possibly with storage of the PCLS at 4°C for at least 44h. 
The mechanism by which amphiregulin induction is regulated by mechanical stress 
seems to be dependent on tyrosine kinases and the cytoskeleton.
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5.4.2. Amphiregulin RNA expression by other stress factors
To investigate amphiregulin induction by stress other than slicing and stretching, we 
treated PCLS with TMA, DNCB and H2O2 (Fig. 4.22). TMA and DNCB cause chemical stress 
in the lungs and have been shown to induce allergic reactions in murine airways (110). 
Oxidative stress, as one contributing stress factor to bronchopulmonary dysplasia 
was investigated by Wagenaar et al., who found an upregulation of amphiregulin in 
response to hyperoxia in neonatal rat lungs (284). We observed no further amphiregulin 
induction by treatment with these substances. Again, this might be due to the massive 
induction by the slicing process. Additionally, we used PCLS from adult rat lungs, 
which may not be comparable to the neonatal rat lungs used by Wagenaar et al. or the 
murine airways that showed allergic reactions to DNCB and TMA.   
However, we could not definitely exclude an effect because the induction could be too 
weak to be distinguished from the slicing effect. 
Taken together, there is a massive amphiregulin induction triggered by the preparation 
process of the PCLS. Others have examined the role of amphiregulin in wound healing 
processes after injury. Amphiregulin seems to be involved in liver fibrosis in mice, and 
it is upregulated after hypoxia in rat gastric mucosal cells (126; 199). Further studies 
support a role of amphiregulin in wound healing processes in damaged human 
colonic mucosa cells (118). Those studies show an involvement of amphiregulin in 
regenerative processes after different stress factors. 
Our data may also suggest a role for amphiregulin in wound healing, probably 
in response to the slicing stimulus, which seems to be stronger than the induction 
triggered by stretch or other stress factors, such as chemicals.
5.4.3. Induction of immune response genes in PCLS
A gene array was performed to reveal information about upregulated genes by 
stretching the PCLS in the bioreactor, in order to find other candidate genes by 
screening. PCLS were stretched in the bioreactor for 2h and 4h and compared to PCLS 
which were clamped for the same time period. Stretched and clamped slices were 
compared to untreated control PCLS and to untreated lung tissue. A relatively huge 
amount of RNA was needed for the gene array; therefore the RNA was pooled from 
6 animals, which reduced the final experiment to one analysis per group. In addition, 
only two bioreactor prototypes to stretch the tissue mean some time limitation. 
Consequently, a statistical evaluation of the data could only be handled with care and 
had to be verified by RTq-PCR. An obvious upregulation of inflammatory genes could 
be found by the untreated PCLS in comparison with untreated tissue. The pattern of 
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the upregulated genes shows a reaction to the mechanical stimulus and seems to 
react with repair mechanisms such as wound healing (Serpine1) and inflammatory 
processes (Il6). Stretched tissue in comparison with clamped controls did not reveal 
many genes specifically upregulated. Genes which appeared upregulated by stretch 
in the microarray could not be verified by RTq-PCR (data not shown). 
The induction of genes triggered by the production process of the PCLS was investigated 
using RTq-PCR. One interesting fact was that the filling of the lung contributed partly 
to the induction of inflammatory mRNA. A completely filled lung lobe was incubated 
at 37°C for 4h, which means they were not sliced. The stimulus is therefore directly 
associated to the expansion of the lung. However, the stress factor which induces the 
main part of the inflammatory gene expression seems to be the slicing procedure. 
Several immune response genes were upregulated in PCLS. Mechanical stress and 
injury of cells during the slicing process as an activator of early immediated genes has 
been adressed in PCLS before (154). Martin et al. investigated Cox-2 as representative 
immediate early gene directly after the slicing process and over time. They observed 
that the induction could be abolished by media changes after the slicing process, 
probably due to the removal of inflammatory mediators released by the slicing 
process (154). We found a significant upregulation of different immune response 
genes after the slicing process, such as IL-6, MIP-2 and IP-10, and also including Cox-2. 
All of them are known to be involved in inflammatory processes, however, Cox-2 was 
not induced in PCLS after the slicing procedure and incubation in previous studies 
(154). Explanation for these different results may be: (i) we did not use the roller culture 
incubation system, so-called dynamic incubation, that was used by Martin et al., but 
did cultivate the PCLS in a static culture system (150; 218), (ii) the Krumdieck tissue 
slicer we used was an older model which may produce slices of non-ideal quality, and 
(iii) we directly quantified the cDNA by SYBR Green intercalation, which may be more 
sensitive than quantification by semi-quantitative PCR that was used before. 
Proinflammatory cytokines are known to be released after tissue injury. During the 
innate immune response cytokines are produced for example by macrophages. 
Recruited T cells, belonging to the adapted immune response release additional 
cytokines enhancing the inflammatory response (150; 177). IL-6 and MIP-2 upregulation 
was highest 24h after the slicing process. Not much is known about RNA levels in rat 
tissue over time during inflammation, however, we found that IL-6, IP-10 and MIP-
2 are produced to a high extend up to 24h after the slicing process. For IL-6 it was 
shown that mRNA expression in endothelial cells and serum levels were at maximum 
4h after the onset of inflammation (142; 311).  The prolonged IL-6 production in PCLS 
in comparison to endothelial cells and serum may be explained by the media changes 
carried out every 30 minutes during the first 4h (142; 311). Inflammatory responses are 
enhanced by positive feedback loops induced by the released mediators. Removal of 
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released mediators may have delayed the inflammatory process and prolonged the 
maximum cytokine production to 24h after the slicing process. 
Cox-2 was upregulated to a certain extent and did not change the expression for the 
next 48h. This could be due to an enhanced basal expression. A long lasting release of 
proinflammatory mediators has been shown for example in sepsis (222).
The amphiregulin response to mechanical stress seems to be maximally upregulated 
after the slicing process. To investigate, wether the inflammatory response may be at 
a maximum too, we treated PCLS with LPS for 4h. LPS is known to upregulate early 
immediate genes, therefore we incubated PCLS with LPS to evalute whether IL-6, MIP-
2, Cox-2 and IP-10 could be induced furthermore. LPS treatment has been applied 
in PCLS by Martin et al., who found an upregulation of Cox-2 expression after LPS 
treatment (154). We observed an induction of IL-6, MIP-2, Cox-2 and IP-10 after LPS 
treatment, which means that the slicing process does not induce the mRNA maximally 
and that slicing and LPS act additively on RNA induction. Although, the induction was 
not significant for IL-6. 
The induction of IL-6, MIP-2, Cox-2 and IP-10 could only be prevented by storage of the 
PCLS at 4°C. Normally, PCLS are incubated at 37°C to mimick the body temperature. 
The absolute prevention of mRNA induction showed the importance of temperature 
for the transcriptional system.
Taken together, there is an inflammatory response induced by the slicing process. 
Unlike amphiregulin, different inflammatory cytokines could be further induced by 
the treatment with LPS. However, the ongoing inflammation was only partly reduced 
after 48h.
5.5. Conclusions
PCLS serve as a model for different clinical problems, such as asthma or overventilation. 
In addition to the use as a method to investigate airway and vascular pharmacology in 
different species, including human material, here we show that they can also be used 
for studying chemical and mechanical stress. 
This is the first time PCLS were prepared from sheep lungs. Sheep PCLS offer the 
possibility to study differences in adult and preterm sheep. The bronchoconstriction 
to various mediators showed different results from adult and preterm sheep and may 
therefore provide a new model to investigate age-dependent stress responses. 
We also show that PCLS as a model to investigate chemical stress is useful to study 
respiratory allergens as required in the REACH (Regulation, Evaluation, Authorisation 
and restriction of CHemicals) process. The specification of EAR and AHR to chemical 
allergens in mice is a promising method to predict the response in vivo. 
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Furthermore PCLS can be used as a new experimental model for studying mechanical 
stress in lung tissue of animals under well defined conditions. PCLS can be stretched in 
the bioreactor for at least 4h without significant cell death. We were able to determine 
stretches applied in our model during the stretching process. A gene induction 
of specific stretch markers in response to the applied stretch was not found in our 
model, probably because of the upregulation of stress genes by the slicing procedure. 
Stretching of precision-cut lung slices represents a link between in vivo and cell culture 
models designed to examine the biomechanical consequences of lung stretch. The 
new model will be useful to further investigate pulmonary sequelae of overdistension 
of lung tissue as may occur during mechanical ventilation. It is planned to extend this 
time span to up to three days, the time that PCLS can survive without cell death or loss 
of biological function (153; 303) and to apply this method to the study of human lung 
slices (218; 303). 
96
6. Summary
6. Summary
Lungs are exposed to different forms of stress such as chemical substances, allergens or 
in the form of direct tissue injury. This study examined whether precision-cut lung slices 
are suitable as a model for studying different types of stress. We established the use of 
PCLS from sheep to study the response of airways and vessels to mediators. According 
to in vivo experiments sheep are thought to represent the human pathophysiology 
better than rodents. We therefore established the use of sheep PCLS and showed that 
methacholine, serotonin and endothelin-1 lead to a bronchoconstriction, while the 
response to leukotriene and thromboxane was rather weak. PCLS were also produced 
from preterm sheep and compared to adult sheep, which revealed a decreased 
reagibility to methacholine and serotonin in preterm sheep. Comparison of the 
bronchoconstriction of sheep PCLS with bronchoconstriction data from human PCLS 
revealed a less satisfactory accordance than the one seen in vivo. Although sheep PCLS 
may not represent the characteristics of human PCLS completely, the results presented 
in this thesis indicate that they are closer to human PCLS than PCLS from rodents.
Another kind of stress that we examined was chemical stress. This study also aimed 
at studying the usefulness of PCLS to study respiratory allergens as required in the 
REACH (Regulation, Evaluation, Authorisation and restriction of CHemicals) process. 
Bronchoconstriction in PCLS as response to chemical allergen was investigated 
and compared to bronchoconstriction in vivo. For this purpose a well established 
sensitisation protocol with TMA, a respiratory allergen and DNCB, a dermal allergen, 
was used. The early allergic response and airway hyperresponsiveness in mouse PCLS 
was investigated and compared to data from in vivo invasive measurements. Acquired 
measurements were comparable suggesting PCLS as a reasonable alternative to 
invasive lung function measurements. Hence, stress-related bronchoconstriction to 
chemical allergens may be a suitable predictability for in vivo experiments. 
Several in vivo and cell culture models have been developed to study the pulmonary 
responses to mechanical stretch. While providing extremely useful information, 
these models do also suffer from limitations in being either too complex for detailed 
mechanical or mechanistic studies, or being devoid of the full complexity present in 
vivo (e.g. different cell types and interstitial matrix). Therefore, we developed a new 
model, based on the biaxial stretching of precision-cut lung slices. Single PCLS were 
mounted on a thin and flexible carrier membrane of PDMS in a bioreactor and the 
membrane was stretched by applying varying pressures under static conditions. A 
gene array revealed a general upregulation of immune response and wound healing 
genes by the slicing process. Stretch markers like amphiregulin were upregulated in 
PCLS by the slicing process. This upregulation was dependent on tyrosin kinases and 
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the cytoskeleton, but could not be blocked sufficiently, which made it complicated to 
differentiate a stretch response from the basal increase.
Distension of the PCLS was modelled via finite element simulation. According to this 
analysis, lung tissue was stretched by up to 38 % in the latitudinal and by up to 44 % 
in the longitudinal direction resulting in alveolar distension similar to what has been 
described in intact lungs. Lung slices were stretched dynamically with a frequency of 
0.25 Hz for 4h, without causing cell injury. This indicates that the distension of PCLS in 
the bioreactor may not be suitable to study gene expression but allow the calculation 
of deformation and occurring forces of the PCLS during the stretching process.
PCLS are a suitable model for studying different forms of stress in the lung and allows 
the investigation of different pathophysiological situations. Additionally, PCLS may 
serve as a link between different species. 
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Die Lunge, die der Atmung dient, ist durch ihre Lage und Funktion vielen verschiedenen
Stressfaktoren ausgesetzt. Diese können in Form von chemischen Substanzen, wie 
zum Beispiel Allergenen und Mediatoren auftreten, oder zu einer direkten Verletzung 
des Lungengewebes führen. In dieser Arbeit wurde untersucht, ob und inwiefern sich 
präzisions-geschnittene Lungenschnitte (PCLS) als Stressmodell eignen.
Ein Teil der vorliegenden Arbeit befasst sich mit der Etablierung des Lungenschnitt-
Modells aus Schafslungen und die Wirkung von Mediatoren auf die Atemwege und 
Blutgefäße. Viele Tiermodelle spiegeln das Krankheitsbild des humanen Asthma 
bronchiale nur unzulänglich wider. In vivo weisen Schafe sehr viele Merkmale des 
humanen Krankheitsbildes auf, deswegen wurde in dieser Arbeit das Modell der Schaf-
PCLS für die Messung der Bronchokonstriktion in Atemwegen und der Vasokonstriktion 
in Blutgefäßen etabliert. Während die Mediatoren Metacholin, Serotonin und 
Endothelin-1 zu einer starken Konstriktion der Atemwege in Schaf- PCLS führten, war 
die Reaktion auf Leukotriene und Thromboxane vergleichsweise schwach.
Neben PCLS aus adulten Tieren wurden auch Lungenschnitte aus frühgeborenen 
Lämmern hergestellt und mit den adulten Schaf-PCLS verglichen. Atemwege aus 
frühgeborenen Schafen zeigten eine abgeschwächte Konstriktion im Vergleich mit 
denen aus adulten Tieren. Vergleicht man die Bronchokonstriktion der Schaf-PCLS 
mit den Literaturdaten humaner Lungenschnitte, so zeigt sich eine weniger gute 
Übereinstimmung der Daten als die in vivo beobachtete Übereinstimmung der 
Asthma-Charakteristika in Menschen und Schafen. Trotzdem bietet das Schaf-PCLS-
Modell einige Vorteile gegenüber dem Nagermodell, zum Beispiel den Vergleich 
von Lungenschnitten aus adulten mit frühgeborenen Schafen. Weiterhin wurde die 
Bronchokonstriktion als Reaktion auf chemische Allergene in PCLS mit der Reaktion in 
vivo verglichen. Hierfür wurde ein bekanntes Maus-Sensibilisierungsprotokoll mit dem 
respiratorischen Allergen TMA, und dem dermalen Allergen DNCB als Modell genutzt. 
Die allergische Frühphase und die Atemwegshyperreagibilität wurden in vitro in 
Maus-präzisionsgeschnittenen Lungenschnitten gemessen und mit in vivo Daten aus 
invasiven Experimenten verglichen. Durch die gute Übereinstimmung der Ergebnisse 
lassen sich PCLS als mögliche Alternative für in vivo Lungenfunktionsmessungen 
in Betracht ziehen. Stress-bedingte Bronchokonstriktion in PCLS durch chemische 
Allergene könnte als Vorhersage für in vivo Experimente dienen und damit für die 
Identifikation von chemischen Allergenen im Zuge der REACH (Regulation, Evaluation, 
Authorisation and restriction of CHemicals)-Richtlinien von Vorteil sein. 
Neben Stress durch chemische Substanzen kann die Lunge auch durch physische Stimuli 
in Form von Überdehnung des Gewebes Schaden nehmen, wie z. B. bei der künstlichen 
Beatmung. Zahlreiche in vivo- und Zellkultur-Modelle wurden entwickelt, um die 
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Auswirkungen von mechanischem Stress auf das Lungenparenchym zu untersuchen. 
Obwohl durch diese Modelle schon viele wichtige Fragen beantwortet wurden, 
weisen sie immer noch einige Defizite auf. Während in vivo- Modelle oft zu komplex 
sind, um mechanische Eigenschaften adequat messen zu können, sind Zellkultur-
Modelle oftmals zu einfach, um die Zusammenhänge der in vivo-Situation zu erfassen 
(beispielsweise verschiedene Zelltypen und die interstitielle Matrix). Deswegen haben 
wir ein neues Modell entwickelt, mit dem präzisions-geschnittene Lungenschnitte 
biaxial gedehnt werden können. Einzelne PCLS wurden auf einer dünnen, flexiblen 
Polydimethylsiloxan- Membran in den Bioreaktor eingespannt und durch Anlegen 
unterschiedlich hohen Druckes statisch ausgelenkt. Durch einen Genarray konnten 
wir weiterhin herausfinden, dass das Schneiden der Lunge an sich schon als physischer 
Stimulus wirkt und eine Anzahl von Genen hochreguliert. Bekannte Dehnungsmarker, 
wie zum Beispiel Amphiregulin, wurden durch den Schneideprozess hochreguliert. 
Bei dieser Induktion scheinen besonders Tyrosinkinasen und das Zytoskelett beteiligt 
zu sein, allerdings ließ sich die Hochregulation nicht vollständig blockieren. Daher 
war es uns nicht möglich, eine spezifisch durch Dehnung im Bioreaktor ausgelöste 
Amphiregulin-Induktion von der basalen Induktion abzugrenzen. Die Dehnung wurde 
mit Hilfe eines Finite-Element Modells untersucht. Dabei zeigte sich eine Dehnung von 
bis zu 38 % in der Breite und bis zu 44 % in der Längsrichtung. Diese Daten entsprechen 
Literaturdaten, die in intakten Lungen erhoben wurden. Die PCLS wurden außerdem 
dynamisch mit einer Frequenz von 0.25 Hz für 4 Stunden im Bioreaktor gedehnt, ohne 
die Zellstruktur zu verletzen.
Die Anwendung von präzisions-geschnittenen Lungenschnitten als Modell für Stress 
in der Lunge hat sich als erfolgreich erwiesen. Verschiedene pathophysiologische 
Situationen der Lunge konnten in den Lungenschnitten untersucht werden. 
Speziesunterschiede stellen immer noch eine Problematik bei der Übertragung von 
Daten aus Tiermodellen auf die humane Situation dar. Daher eignen sich präzision-
geschnittene Lungenschnitte besonders, die pulmonalen Reaktionen in verschiedenen 
Spezies zu untersuchen.
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